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The objective of this thesis are visual misperceptions and behavioral variability, their 
neural correlates and their potential for differential diagnosis of non-motor symptoms 
profiles in Parkinson’s disease (PD). This thesis investigates 1) objective and 
quantifiable measures of visual misperceptions and behavioral variability in PD and      
2) functional connectivity correlates of visual misperceptions and behavioral variability 
3) neural and cardiac correlates of behavioral variability in cognitive aging.  
In Chapter 2, we investigated task derived objective and quantifiable measures of visual 
misperceptions and behavioral variability in PD patients reporting visual hallucinations 
(VH) and PD patients without VH. First, PD patients with and without VH were 
compared with age matched healthy control group. Second, we compared PD patients 
reporting VH with PD patient who did not report VH. In addition, we investigated the 
relation between severity of perceptual errors, intra-individual variability of recognition 
times and fuctional connectivity estimates of Resting state networks in PD patients.  
We could show that PD patients who reported VH make more percpetual errors and 
show more intra-individual variability in recogntion time. In a subsample of PD patients, 
who participated in an functional Magnetic Resonance Imaging (fMRI) resting state 
experiment, a higher perceptual error score was related to hypoconnectivity between 
dorsal attention- and salience network. Increased intra-individual variability with respect 
to recognition time was related to hypoconnectivity between the somatomotor- and right 
fronto-parietal network.  
Perceptual errors and the hypoconnectivity between attentional networks might be a 
promising objective measurement to estimate the risk for VH of PD patients. The 
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determination of behavioral variability and hypoconnectivity between the somatomotor- 
and  fronto-parietal network might be a useful to determine cogntive decline. 
Behavioral variability is increased in different disorders like attention deficit hyperactivity 
disorder (ADHD), obsessive-compulsive disorder (OCD), impulse control disorder (ICD) 
(Abramovitch, McCormack, Brunner, Johnson, & Wofford, 2019; Kertzman et al., 2018; 
Kofler et al., 2013), schizophrenia (Rentrop et al., 2010), dementia (Costa, Dogan, 
Schulz, & Reetz, 2019), Huntington Disease (Musso et al., 2015) and in untreated PD 
patients (Burton, Strauss, Hultsch, Moll, & Hunter, 2006; Camicioli, Wieler, de Frias, & 
Martin, 2008) which are characterized by cognitive decline. Until now the source of 
behavioral variability is not fully understood. Behavioral variability might be explained by 
variability quenching, a novel measurement which is until now investigated in healthy 
young individuals (Arazi, Censor, & Dinstein, 2017; Arazi, Gonen-Yaacovi, & Dinstein, 
2017). In Chapter 3 we investigated age related cognitive decline. First, we compared 
behavioral variability, event-related potentials such as P1 and P3, change in power of 
alpha, beta, gamma and theta frequency, neural variability (variability quenching) and 
cardiac variability (HRV) between healthy elderly and healthy young volunteers. Second 
we tested the relation between standardized cognitive measures, task derived 
measures such as intra-individual variability, neural measures and cardiac measures in 
healthy young and healthy elderly. Healthy elderly show higher behavioral variability, 
lower P1 and P3 amplitude, lower theta power and lower cardiac variability. Lower 
cognitive performance in healthy elderly is related to higher behavioral variability and to 
lower neural variabiltiy. To conclude the measurement of behavioral- and neural 
variability are promising marker of cognitive decline. Perceptual errors in combination 
with hypoconnectivity between the dorsal attention network and the salience network 
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might be a promising tool to indicate PD patients at risk for experience of visual 
misperceptions and visual hallucinations. The analysis of behavioral variability 
combined with hypoconnectivity between somatomotor- and the fronto-parietal network 





ADHD: attention deficit hyperactivity disorder  
BDI: Beck’s Depression Inventory 
CFS: Continuous Flash Suppression  
CNS: Central Nervous System  
CVRT: Coefficient of Variability in Recognition Time 
DAN: dorsal attention network 
DMN: default mode network 
ECG: Electrocardiogram  
EEG: Electroencephalogram  
fMRI: functional Magnetic Resonance Imaging 
HRV: Heart Rate Variability 
LEDD: Levodopa-Equivalent Daily Dose  
LB: Lewy Bodies 
MCI: Mild Cognitive Impairment 
MMSE: Mini Mental State Examination 
PD: Parkinson’s Disease 
PD-MCI: mild cognitively impaired PD 
PD-nonVH: Parkinson patients without visual hallucinations 
PD-VH: Parkinson patients with visual hallucinations 
PES: Perceptual Error Score 
RBD: Rapid eye movement disorder 
SAL: salience network 
TMT: Trail Making Test 
OCD: obsessive-compulsive disorder  
ICA: Independent Component Analysis 
ICD: impulse control disorder  
VAN: central attention network 
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VH: visual hallucinations 







1. General Introduction 
Parkinsons’ Disease (PD) is a neurodegenerative disorder which progresses in motor 
and non-motor symptoms (Nagatsu, Nakashima, Ichinose, & Kobayashi, 2018). It is 
variable in disease onset and course, having a diverse clinical picture (Sethi, 2002). To 
classify the heterogeneous symptoms disease stages as well as subtyping in different 
syndromes are used (Linazasoro, 2007). Classically, PD is known as a hypokinetic 
movement disorder with its prominent motor symptoms such as bradykinesia, rigidity 
and resting tremor. These motor symptoms result from dysfunction of the Central 
Nervous System (CNS) due to neuronal loss in the Substantia Nigra pars compacta and 
occurrence of abnormal cell deposits, Lewy Bodies (LB) (Graybiel, 2005; Kalia & Lang, 
2015). In addition to the CNS  other brain structures which are part of the autonomous 
nevous system such as the cerebellum, locus coeruleus and the pedunculopoontine 
nucleus are affected (Braak & Del Tredici, 2017; Kalia & Lang, 2015; Obeso et al., 
2017). This indicates that PD is a syndrome where dysfunction of multiple systems is 
involved, which might provide explanation for non-motor symptoms with involvement of 
autonoumous dysfunction (Braak & Del Tredici, 2017; Kalia & Lang, 2015; Obeso et al., 
2017). Dysfunction of the fronto-parietal network seems to be involved in cognitive 
impairment and visual hallucinations (Haber, 2014; Gratwicke, Jahanshahi & Foltynie, 
2015; Trojano & Papagno, 2018). The involvement of different neural systems might 




1.1. Non-Motor Symptoms in Parkinson’s Disease 
Different neural pathways such as the negrostiatal pathway which is important for 
movement and the mesolimbic pathway which is important for reinforcement and 
emotional processes, are affected in PD (Trojano & Papagno, 2018). Disruption of these 
pathways might contribute to impairments in different non-motor domains (Trojano & 
Papagno, 2018). PD patients show therefore diverse non-motor symptoms such as 
sleep, sensory, autonomic, cognitive and neuropsychiatric disturbances (Adler, 2011; 
Park & Stacy, 2009; Reichmann, Brandt, & Klingelhoefer, 2016; Trojano & Papagno, 
2018). 
1.1.1. Sensory 
Sensory changes consist of olfactory decrease, pain, restless legs syndrome and visual 
impairments (Park & Stacy, 2009). Early symptoms are hyposmia experienced in 70 - 
100% of PD patients (Katzenschlager & Lees, 2004) and shoulder pain (Stamey, 
Davidson, & Jankovic, 2008). Chronic pain is experienced by 40 % of PD patients and 
coocurs with increase in other complains such as motor symptoms and mood changes 
or higher depression (Nègre-Pagès et al., 2008). Diverse and progressive deficits (Levin 
et al., 1991) can occur at an early stage (Foltynie, Brayne, Robbins, & Barker, 2004)  in 
areas of visual perception such as visual acuity, contrast sensitivity, color discrimination, 
motion perception, peripheral visual field sensitivity and visual processing speed 
(Diederich, Raman, Leurgans, & Goetz, 2002; Uc et al., 2005), perception of 
extrapersonal space (Montse, Pere, Carme, Francesc, & Eduardo, 2001) and facial 





Sleep disorders such as early morning awakenings, sleepiness during the day, sleep 
attacks, advanced sleep phase syndrome, and rapid eye movement disorder (RBD) 
occur in 60 to 98% of PD patients (Stacy, 2002). RBD is characterized by acting out 
dreams during rapid eye movement sleep phase. Interestingly, RBD is an early, even 
premotor symptom of PD (Adler, 2011). Moreover, RBD and PD patiens show 
autonomic dysfunction indicated by reduced heart rate variability (HRV) (Valappil et al., 
2010). Furthermore, RBD is related to more rapid progression of PD and occurrence of 
dementia and hallucinations (Fereshtehnejad et al., 2015; Kim & Jeon, 2014; Romenets 
et al., 2012). 
1.1.3. Autonomic dysfunction 
Autonomic disturbances consist of nausea, constipation, excessive sweating, 
constipation, urogenital problems, cardiac problems, orthostatic hypotension and HRV 
(Adler, 2011; Park & Stacy, 2009). Constipation is frequently reported and precedes 
motor symptoms (Abbott et al., 2001). An early occuring cardiac abnormality is the 
myocardial postganglionic sympathetic dysfunction (Iwasa et al., 1998). Decrease in 
HRV occurs also in PD patients who were not exposed to medication and might be a 
potential marker at an early disease stage (Ferini-Strambi, Franceschi, Pinto, Zucconi, 
& Smirne, 1992; Kallio et al., 2004; Mihci, Kardelen, Dora, & Balkan, 2006). 
1.1.4. Neuropsychiatric disturbances 
Neuropsychiatric disturbances include apathy, depression, anxiety, disorders of 
emotional processing, impulse control disorders, cognitive impairment, psychosis and 
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hallucinations (Bertram & Williams, 2012; Cosgrove, Alty, & Jamieson, 2015; Eversfield 
& Orton, 2018; Trojano & Papagno, 2018). Depression and anxiety are associated in 
PD and occur in 19%, respectively 30% of PD patients (Broen, Narayen, Kuijf, 
Dissanayaka, & Leentjens, 2016; Goodarzi et al., 2016). Both are related to other non-
motor symptoms. Anxiety predicts cognitive decline and depression which is related to 
executive dysfunction and apathy (Pirogovsky-Turk et al., 2017; Santangelo et al., 2015; 
Varanese et al., 2010). Apathy occurs in 20% of PD patients and is present in the 
prodromal phase (Pagonabarraga, Kulisevsky, Strafella, & Krack, 2015; Varanese, 
Perfetti, Ghilardi, & Di Rocco, 2011). Apathy is also associated with executive 
impairments and predicts development of dementia (Santangelo et al., 2015). Another 
non-motor symptom, which is related to executive impairments is impulse control 
disorders (ICD) consisting of compulsive behavioral manifestations such as gambling, 
compulsive shopping and hypersexuality (Santangelo et al., 2007; Weintraub et al., 
2015). It is already present at an early disease stage but increases with dopaminergic 
medication (de la Riva, Smith, Xie, & Weintraub, 2014). Most of the neuropsychiatric 
symptoms, apathy, depression, anxiety and ICB are related to cognitive changes 
indicating a general cognitive dysfunction in PD. Cognitive changes such as dementia 
are diagnosed with dementia in approximately 30% of the PD patients (Park & Stacy). 
These demented patients are characterized with deficits in information processing 
speed, especially in visuospatial, attentional and executive processing and fluctuations 





1.1.5. Visual Hallucinations  
Visual hallucinations (VH) are perceptions without the presense of an external stimulus. 
Visual misperceptions are illusory or distorted percepts in presence of an external 
stimulus (Bertram & Williams, 2012). VH prevalence in PD is between 15 – 75% 
(Aarsland et al., 1999; Eversfield & Orton, 2018; Fénelon, Mahieux, Huon, & Ziégler, 
2000; Hely, Reid, Adena, Halliday, & Morris, 2008; Sanchez-Ramos, Ortoll, & Paulson, 
1996; Williams & Lees, 2005). Variance in prevalence can be explained by different 
study methods (Bertram & Williams, 2012). Studies cooperating with specialized 
movement disorders facilities report a prevalence between 25 to 50%(Fénelon et al., 
2000; Sanchez-Ramos et al., 1996). Most studies described occurrence of complex or 
formed VH such as people, animals or objects (Bertram & Williams, 2012). Minor 
hallucinations consisting of visual misperceptions, passage hallucinations (sense of 
movement in the periphery) and ‘presence’ hallucinations (feeling of a presence in the 
room) might be prehallucinatory symptoms (Fénelon et al., 2000) proceeding to 
psychosis with occurrence of delusion and loss of insight into hallucinations (Goetz & 
Stebbins, 1993). PD patients do mostly not report minor hallucinations or 
misperceptions as hallucinatory experiences. These experiences are only shared by 
direct questioning (Williams, Warren, & Lees, 2008). This fact brings to light that 
measuring visual misperceptions might be usefull for recognizing individuals at risk for 
development of VH. In general, VH are reported in the later stages of PD (Williams & 
Lees, 2005). However, we do not know whether the occurrence of VH is simply 
underreported at earlier stages because patients are not feeling comfortable to report 
the experience of VH due to the fear of being judged or because they may not be aware 
of the hallucinatory/illusory experience. Given that VH is a reliable predictor of dementia 
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(Lee, Tsai, Gauthier, Wang, & Fuh, 2012; Santangelo et al., 2007) with 70% prevalence 
(Fénelon et al., 2000) recognizing risk groups for development of VH and cognitive 
decline might improve management of the symptoms and thereby reduce distress in 
patients and their caregivers (Dudley et al., 2012). Patients might be unaware of, 
underestimate, underreport or hide the experience of socially undesirable symptoms 
such as VH. For this reason, it is important to have an objective and quantifiable 
assessment tools for VH. These tools can provide accurate differential diagnosis to 
correctly inform the patient about their diagnosis and its prognosis, to plan adequate 
treatment and possibly evaluate treatment in the future. 
1.2. Neuropsychological Diagnostic and Assesment Tools of Non-Motor 
Symptoms 
Non-motor symptoms are measured by patient report with standardized non-motor 
symptoms questionnaires such as the Non-motor Symptom Questionnaire (NMSQuest) 
(Chaudhuri et al., 2006). It is assessing gastrointestinal symptoms, urinary symptoms, 
sexual function, sleep/fatique, pain and miscellaneous symptoms, and Non-Motor 
Symptoms Scale (NMSS) (Chaudhuri et al., 2007) containing items about 
cardiovascular symptoms, sleep/fatique, mood, cognition, perception, sexual function 
and miscellany symptoms (Goldman et al., 2014). As reviewed in (Kulisevsky & 
Pagonabarraga, 2009) different rating scales asses different symptoms such as sleep 
with the Epwoth Sleepiness Scale (ESS), Pittsburg Sleep Quality Index (PSQI), fatique 
with the Fatique Severity Scale and autonomic symptoms with the SCOPA-autonomic 
scale (Goldman & Postuma, 2014). Impulse control disorders such as compulsive 
gambling, shopping, sexual behavior and eating are measured with the Questionnaire 
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for Impulsive-Compulsive Disorders in Parkinson’s Disease (Weintraub, Papay, 
Siderowf, & Parkinson’s Progression Markers Initiative, 2013). Often cognitive 
symptoms are measured using scales which are not specific for PD (Kulisevsky & 
Pagonabarraga, 2009) such as the Montreal Cognitive Assessment (MoCA), Mini-
Mental State Examination (MMSE) (Goldman & Postuma, 2014), Cambridge Cognitive 
Assessment, Frontal Assessment Battery (FAB) and Mattis Dementia Rating Scale 
(Kulisevsky & Pagonabarraga, 2009). To detect early cognitive deficits in PD the Scales 
for Outcomes of Parkinson’s Diasese Cognition and the Parkinson’s Disease – 
Cognitive Rating Scale, which is also sensitive to the transition to dementia in PD, are 
recommended (Kulisevsky & Pagonabarraga, 2009). Mattis Dementia Rating Scale 
shows excellent discrimination for dementia in PD (Kulisevsky & Pagonabarraga, 2009). 
Also given that VH often occur in dementia additional screening tools are needed to 
accurately assess this symptom. Patients do not always want to share their 
hallucinatory experience. Clinicians and researchers need to interview the patients to 
classify these symptoms. Rating scales can be used to standardize the interview 
procedure and to scale the severity of the hallucinatory experience. Rating scales are 
available but there is no standardized procedure for assessment of halucinations in PD 
(Kulisevsky & Pagonabarraga, 2009). Hallucinations can be measured with the 
Neuropsychiatiric Inventory, item 2 of the Movement Disorders Society Unified 
Parksinons’s Disease Rating Scale (MDS-UPDRS) (Kulisevsky & Pagonabarraga, 
2009) and the Parkinson Psychosis Rating Scale (Fernandez et al., 2008). Separate 
assessment of VH is possible with the University of Miami Parkinson's disease 
Hallucinations Questionnaire UM-PDHQ (Papapetropoulos et al., 2008). However, 
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this assesment neglects the full range of hallucinatory experience such as minor 
hallucinations, visual misperceptions and passage hallucinations. 
The above described procedures provide standardization to the assessment of non-
motor symptoms. However, these measurements has still the weaknes not assesing the 
full range of symptoms such as VH and they are not objective because the patient can 
still deceive him- or herself and the examinator. To prevent this, objective 
measurements can be derived from responses to a task. These can be used to detect 
patient groups at risk for different symptom profiles.  
1.3. Task Responses 
In an object recognition task with noise degraded images, hallucinating PD patients 
needed more time for image recognition (Meppelink, Koerts, Borg, Leenders, & van 
Laar, 2008). In reaction time tasks performance variability predicted transition from MCI 
to dementia (Gorus, De Raedt, Lambert, Lemper, & Mets, 2008; Tales et al., 2012). 
Interestingly, increase in behavioral variability charcterized PD patients with MCI and 
dementia (de Frias, Dixon, & Camicioli, 2012). Previous research in hallucinating PD 
patients showed that these patients make more perceptual errors in a task using 
ambiguous images to PD patients who did not report experience of VH (Shine, Keogh, 
et al., 2015). Thus, different symptom profiles in PD are characterized by differences in 
task derived responses such as hallucinating PD patient by increased in perceptual 
errors and cognitively impaired PD patients by increased behavioral variability. 
The above described approach using task dereived responses impoves objectivity of 
the measure identifying patients being at risk for VH. However, patients still could try to 
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show desirable behavior by responding in a way they think they are expected to perform 
or simply misunderstanding, confuse or forget the instructions. To improve this, the task 
can be combined with cardiac and neural measurements such as electrocardiogram 
(ECG) and electroencephalogram (EEG) respectively. 
1.4. Cardiac measurements 
The cardiac function is influenced by parasympathetic supression via cingulate cortex 
and sympathetic activation via the insula. These are part of the Ventral Attention 
Network involved in attentional dysfunction of the hallucinating PD patients (Shine et al., 
2015). As already mentioned previously, lower HRV is related to higher risk of PD and 
might be an early marker of PD (Ferini-Strambi et al., 1992). Whether HRV might also 
indicate other non-motor changes such as executive dysfunctions is unknown. In other 
groups such as healthy elderly HRV seems to be an indicator of self-regulatory control 
with higher HRV during Resting state being related to better performance in executive 
functions (Shaffer, McCraty, & Zerr, 2014) and lower HRV to cognitive decline (Frewen 
et al., 2013). Cognitive changes in healthy elderly might be objectively measured by 
behavioral variability and reflected in cardiac variability. However, both measurements 
might be modulated by neural processes such as neural variability and objectively 
indicated by EEG derived measures. 
1.5. Task correlates of EEG 
Different task related neural measurements can be derrived from EEG combined with a 
task. Visually evoked Potentials allow investigation of time-dependent aspects of distinct 
visual processes, reflecting dysfunction in form of amplitude changes (Matsui et al., 
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2006), changes in spectral power of different frequencies and neural variability (Arazi, 
Censor, et al., 2017; Arazi, Gonen-Yaacovi, et al., 2017). 
1.5.1. Neural variability and cognitive changes in healthy populations 
Non-motor symptoms such as cognitive changes might be indicated by performance 
fluctuations at the behavioral level. However, neural variability might provide a more 
objective tool to measure cognitive changes. One possible measurement of neural 
variability is variability quenching, described as the reduction of neural variability after 
stimulus presentation. Higher variability quenching correlates with better perceptual 
performance in healthy young individuals  (Arazi, Censor, et al., 2017). Older and 
slower performing adults showed less brain variability (Garrett, Kovacevic, McIntosh, & 
Grady, 2013), indicating its potential as objective measures of cognitive changes. 
Neural variability magnitudes measured by EEG recordings are stable over time and 
across tasks in healthy young human volunteers (Arazi, Gonen-Yaacovi, et al., 2017) 
showing its reliability as a possible marker of cognitive changes. Before testing neural 
variability in clinical populations its sensitivity in relation to behavioral variability, 
standardized cognitive measures and cardiac variability needs to be validated in 
populations showing age related cognitive changes to prove its potential indicating 
subtle cognitive changes. Neural variability is measured by variability quenching as a 
marker of age related cognitive changes was not yet investigated in different healthy 
populations such as healthy young and healthy elderly. Age related cognitive changes 
in relation to behavioral, neural and cardiac variability might provide interesting insights 




1.5.2. Parkinson’s disease 
Non-motor symptoms in age related neurodegenerative disorders such as PD are 
related to changes in neural measurements such as EEG (Geraedts et al., 2018). 
Previous EEG research had shown that different frequency bands are related to 
different functions in PD. Depression in PD is expressed in lower alpha (Filipović, 
Covicković-Sternić, Stojanović-Svetel, Lecić, & Kostić, 1998). Decrease in alpha and 
beta power reflects cognitive dysfunction (Caviness et al., 2007; Soikkeli, Partanen, 
Soininen, Pääkkönen, & Riekkinen, 1991) and increase in beta power (He, Zhang, 
Chen, Xie, Gan, Yang, et al., 2017) and alpha amplitude is related to motor symptoms 
such as the Hoehn and Yahr stage of PD (Fonseca, Tedrus, Letro, & Bossoni, 2009). 
Higher beta power is related to longer disease duration (Moisello et al., 2015). L-dopa 
administration can increase alpha and beta power (Melgari et al., 2014). These findings 
indicate that alpha and beta reflect motor and non-motor changes such as mood and 
cognitive dysfunction in PD. 
Higher theta power correlates with motor symptoms such as higher desease stage (He, 
Zhang, Chen, Xie, Gan, Wang, et al., 2017) and non-motor symptoms such as higer 
REM sleep disorder scores (Gagnon et al., 2004) and cognitive decline (Bonanni et al., 
2008; Caviness et al., 2007, 2016; Fonseca et al., 2009; Pozzi et al., 1994; Soikkeli et 
al., 1991). Moreover, higher theta power is predictive for cognitive deterioration in PD 
indicating its potential as a marker of cognitve decline (Caviness et al., 2016; Cozac et 





1.5.3. Visual Halucinations  
Previous research in different groups susceptible to hallucinatory experience proposes 
different interesting possible marker of VH  derived from EEG. Previous research had 
shown that healthy individuals susceptible to VH have increased P1 amplitude 
(Schwartzman, Maravic, Kranczioch, & Barnes, 2008) and increased gamma 
synchronization (Becker, Gramann, Müller, & Elliott, 2009). Studies in clinical groups 
experience VH such as PD patients had shown deviant P1 (Matsui et al., 2006), 
delayed P200 (Kurita, Murakami, Takagi, Matsushima, & Suzuki, 2010), increased P3 
latencies (daSilva Morgan, Elder, Ffytche, Collerton, & Taylor, 2018; Kurita et al., 2010) 
and decreased alpha power (Bonanni et al., 2008; Bosboom, Stoffers, Stam, Berendse, 
& Wolters, 2009). Alzheimer patients showed increased occipital and temporal theta 
activity (Lopez et al., 1991) and in LB dementia reduced theta synchronization (Peraza 
et al., 2018). Changes in P1, P3, alpha, gamma and theta power might be potential 
markers of VH in PD. Given that P1 is an early perceptual component it should reflect 
perceptual deficits and P3 as a later more cognitive influenced component reflecting 
attentional and cognitive deficits (daSilva Morgan et al., 2018).  
The above described method using task evoked EEG measures are objective, 
quantifable and not biased by desirable behavior or misunderstanding of task 
instructions. However, these measurements might still be influenced by the 
unintentional suggestions of the experimenter that one kind of stimuli is more important 
than another resulting in more attention of the subject to a specific stimulus condition. 
Another difficulty is the compliance or availability of ressources such as attention by the 
volunteer. Especially more cognitively or executively impaired volunteers such as PD 
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patients suffering from stronger disease progression have difficulties to keep the 
mandatory level of attention, understand and remember the instructions. To improve 
this limitations, neural and cardiac activity can be measured while the volunteer is 
resting. 
1.6. Resting state  
Resting state describes data collection during a task-free, so called resting period. 
Volunteers are instructed to lay still and stay awake while keeping eyes open or closed 
for around 6 to 10 minutes, without executing a specfic task and let their mind wander 
without focusing on a specific topic. In the eyes open resting state a fixation object such 
as a fixtion cross in the center of the monitor is presented to prevent eye-movements 
(Vanderwal, Kelly, Eilbott, Mayes, & Castellanos, 2015). There is more than one 
possiblity to analyze resting state fMRI data. In general, analyses can be categorized in 
two approaches, 1) model-dependent such as correlating the data of a predefined brain 
regions (“seed”) against the time-series of other regions, 2) model-free methods such as 
principal conmponent analysis or independent component analysis (ICA) where 
connectivity patterns are analyzed without predefining “seed” regions (van den Heuvel & 
Hulshoff Pol, 2010). Figure 1.1 shows an overview of the most common Resting state 
networks, such as the default mode network (DMN), sensorimotor network, insular-
temporal network, salience network, parieto-frontal network and the visual network 
(Prell, 2018). Relating functional connectivity estimates of within and between network 
connectivity and symptom severity of different symptom profiles might provide potential 
diagnostic candidates for risk groups with certain symptoms profiles (Hohenfeld, 




Figure 1.1: Overview of resting state networks. The figure summarizes resting-state networks, 
functionally related regions, such as the default mode network, sensorimotor, insular-temporal and 
anterior cingulate cortex regions, salience, executive control and the visual network (Prell, 2018). 
 
1.6.1. Imaging of non-motor symptoms  
1.6.1.1. Fatique 
Tiredness or fatique in PD is related to activity of frontal cortex and anterior cingulate (Li 
et al., 2017) and hypoconnectivity of temoral, parietal and motor cortices (Zhang et al., 
2017). Fatique is related to hypoconnectivity of sensorimotor and DMN in PD (Tessitore 
et al., 2016). Fatique seems to be characterized by reduced FC between sensorimotor 
and DMN and within the Ventral Attention Network (VAN). 
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1.6.1.2. Impulse Control Behavior 
In general impulsive control behaviors (ICB) such as gambling, binge eating, 
compulsive sexual behavior and compulsive shopping are related to changes in brain 
function of fronto-striatal and fronto-limbic circuits (Prell, 2018). Already drug-naïve PD 
patients show hypoconnectivity between DAN and executive network and 
hyperconnectivity within the saliency network indicating that cognitive and limbic 
connectivity changes predict ICB without ivolvement of dopaminergic medication 
(Tessitore et al., 2017). Moreover, hypersexual PD patients exposed to sexual cues 
show changes in limbic, paralimbic, temporal, occipital, somatosensory and prefrontal 
cortices (Politis et al., 2013). In the above described networks different brain areas are 
involved in multiple dysfunctions of multiple non-motor symptoms such as 1) fronto-
parietal areas are involved in cognition, fatique and ICB 2) somatosensory/ 
sensorimotor areas in fatique and ICB indicating probably an common mechanisms to 
this non-motor symptoms (Prell, 2018). 
1.6.1.3. Cognition 
Metabolism in prefontal, temporal and parietal cortex is reduced in mild cognitively 
impaired PD (PD-MCI) and seems to spread to the anterior cingulate cortex (Huang et 
al., 2008; Yong, Yoon, An, & Lee, 2007). Hypoconnectivity within the DMN seems also 
to play a role in cognitive changes in PD (Tahmasian et al., 2017). Connectivity between 
the dorsal attention networks and insula, as well as frontal areas is reduced in PD-MCI 
(Baggio et al., 2015).  In addition, connectivity between DMN and posterior brain 
regions is increased in PD-MCI (Baggio et al., 2015). Cognitive changes in PD seem to 
be related to connectivity of the DMN, dorsal attentional network and frontal brain areas. 
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1.6.1.4. Visual Halucinations  
Previous Resting state studies show hyperconnectivity within the DMN which is a task-
negative network, active while no task is executed, especially of the fronto-parietal 
regions in hallucinating PD patients (Franciotti et al., 2013; Yao et al., 2014). Reduced 
visuospatial memory performance is related to increased functional connectivity 
between hippocampus and occipito-temporal brain areas in hallucinating PD patients 
(Yao et al., 2016). However in another sample of hallucinating patients with LB 
dementia hallucinations were related to functional connectivity of the left fronto-parietal 
and sensorimotor networks (Peraza et al., 2014). Interestingly, objectively measured 
perceptual errors in hallucinating PD patients are related to less functional connectivity 
between the VAN and the dorsal attention network (DAN) providing evidence that VH 
might result from attentional impairments (Shine, Keogh, et al., 2015). Resting state 
functional connectivity of the DMN, visual, sonsorimotor, fronto-parietal and attentional 
networks seem to be involved in VH in PD.  
1.7. Outline of the Thesis 
The objective of the thesis are visual misperceptions and behavioral variability in PD. 
This thesis investigates 1) objective and quantifiable measures of visual misperpections 
and behavioral variability in PD, 2) functional connectivity correlates of visual 
misperceptions and behavioral variability in PD and 3) neural and cardiac correlates of 
behavioral variability in cognitive aging comparing healthy young and healthy elderly 
adults to investigate the potential of different sources of variability as potential marker of 
age related cognitive decline. In the first part of the thesis, Chapter 2, we investigated 
task derived objective and quantifiable measures of visual misperceptions and 
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behavioral variability in PD patients with VH and PD patients without VH and age 
matched healthy controls. In addition, we investigated the relation between severity of 
perceptual errors, intra-individual variability of recognition times and the relation to 
fuctional connectivity estimates of resting state networks in PD patients. The second 
part of the thesis investigated cognitive aging and its behavioral, neural and cardiac 
correlates. Chapter 3, shows differences in behavioral variability, Event-Related 
Potentials, P1 and P3, change in power of alpha, beta, gamma and theta frequency 
bands, neural variability (variability quenching) and cardiac variability (HRV) between 
healthy elderly and healthy young voluteers and the relation between standardized 
cognitive measures, task derived measures such as intra-individual variability, neural 
measures and cardiac measures. The results of our clinical and healthy samples of 
visual misperceptions and behavioral variability are discussed in the broader context of 
differential diagnosis as possible diagnostic marker of visual halluciantions and 
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Patients with Parkinson’s disease (PD) frequently suffer from visual misperceptions and 
hallucinations, which are difficult to objectify and quantify. We aimed to develop an 
image recognition task to objectify misperceptions and to assess performance 
fluctuations in PD patients with and without self-reported hallucinations. Thirty-two non-
demented patients with Parkinson’s disease (16 with and 16 without self-reported visual 
hallucinations) and 25 age-matched healthy controls (HC) were tested. Participants 
performed a dynamic image recognition task with real and scrambled images. We 
assessed misperception scores and intra-individual variability in recognition times. In a 
subsample of Parkinson’s disease patients (N = 16) we related resting state network 
connectivity to the behavioral outcomes. We found that PD patients with self-reported 
hallucinations (PD-VH) exhibited higher perceptual error rates and higher intra-
individual variability in recognition times than PD patients without visual hallucinations 
(PD-nonVH). Both, misperceptions and intra-individual variability were negatively 
correlated with resting state functional connectivity involving frontal and parietal brain 
regions, albeit in partly different subregions. Consistent with previous research 
suggesting that hallucinations arise from dysfunction in attentional networks, 
misperception scores correlated with reduced functional connectivity between the dorsal 
attention and salience network. Intra-individual variability correlated with decreased 
connectivity between somatomotor and right fronto-parietal networks. We conclude that 
our task can detect visual misperceptions that are more prevalent in PD-VH patients. In 
addition, fluctuating visual performance appear to be a signature of PD-VH patients, 
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which might assist further studies of the underlying pathophysiological mechanisms and 
cognitive processes.  
2.1. Introduction 
Patients with Parkinson’s disease (PD) frequently experience non-motor symptoms 
such as cognitive and perceptual deficits (Armstrong, 2011). Visual misperceptions and 
visual hallucinations (VH) involving complex images are highly prevalent, have a 
negative impact on quality of life and represent a key predictor for dementia with 
disease progression (Diederich, Fénelon, Stebbins, & Goetz, 2009). In clinical studies, 
the presence of hallucinations is typically assessed with questionnaires such as the 
University of Miami Parkinson's disease Hallucinations Questionnaire  (UM-
PDHQ) (Papapetropoulos et al., 2008) that do not discriminate between hallucinations 
and misperceptions and thus these concepts appear entangled in the majority of studies 
(for exceptions see: (Shine, Halliday, Carlos, Naismith, & Lewis, 2012)). Visual 
hallucinations are more likely to occur at advanced disease stages and are co-morbid 
with REM sleep disorder (Manni et al., 2011), cognitive and attentional dysfunction 
(Koerts et al., 2010; Meppelink et al., 2008; Shine, Halliday, et al., 2014) as well as with 
sensory impairments such as reduced visual acuity, color and contrast sensitivity 
(Matsui et al., 2006; Pieri, Diederich, Raman, & Goetz, 2000; Ramirez-Ruiz, Junque, 
Marti, Valldeoriola, & Tolosa, 2007). These influencing factors suggest that 
hallucinations in PD patients are modulated by both top-down and bottom-up, sensory 
deficits (Muller, Shine, Halliday, & Lewis, 2014). Functional models further implicate that 
VH’s occur as a consequence of reality monitoring due to the misattribution of self-
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generated information (Collerton, Perry, & McKeith, 2005). A recent hypothesis of 
dysfunctional connectivity between the dorsal attention network (DAN) and the ventral 
attention network (VAN) arises from functional imaging studies in PD patients (Shine, 
Keogh, et al., 2015). Specifically, Shine, Keogh, et al., 2015 showed that impaired 
functional connectivity is related to higher rates of misperceptions in (self-reported) 
hallucinating PD patients.  
Although there has been considerable progress in recent years, visual misperceptions 
and hallucinations in PD remain poorly understood and are difficult to track and to treat. 
Thus, the availability of objective and quantifiable measures is needed to improve 
differential diagnosis, identification of risk groups, disease prognosis and treatment 
options. 
The aim of the present study was to derive a quantifiable trial-based measure to 
investigate misperceptions and intra-individual variability and relate those behavioral 
markers to resting state functional connectivity. To our knowledge, intra-individual 
variability and its neuronal signature has not been investigated as a potential marker of 
visual misperceptions/hallucinations in PD, although intra-individual performance 
fluctuations have been described as sensitive markers to detect subtle cognitive deficits 
in a wide range of psychiatric and neurological diseases such as autism, head injury 
and dementia (MacDonald, Li, & Bäckman, 2009). Previous research in schizophrenia 
and drug-induced psychosis also suggests a direct link to hallucinations (Fassbender, 
Lesh, Ursu, & Salo, 2015; Fassbender, Scangos, Lesh, & Carter, 2014; Rentrop et al., 
2010). Cognitive fluctuations, which might be reflected in task performance variability, 
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are related to desynchronization of fronto-parietal networks in patients with Lewy Body 
Dementia which is characterized by hallucinations (Peraza et al., 2014).  
Based on previous research showing increased occurrence of visual misperceptions as 
measured in psychophysical tasks in PD patients with self-reported hallucinations 
(Koerts et al., 2010; Meppelink et al., 2008; Shine et al., 2012; Shine, Keogh, et al., 
2015; Shine, Muller, et al., 2015), we employed a dynamic image recognition paradigm 
where image contrast was stepped up and subjects reported the detection of a face or 
car image while rejecting a scrambled version. Since it is unclear how conscious image 
perception contributes to the sensitivity of behavioral markers of VH, we also 
implemented a Continuous Flash Suppression condition (CFS) to reduce perceptual 
awareness (Tsuchiya & Koch, 2005). We calculated perceptual error scores and 
recognition time variability and correlated those outcome parameters to resting state 
functional connectivity as assessed with functional magnetic resonance imaging (fMRI). 
We tested the following hypotheses: 1) PD patients with self-reported visual 
hallucinations will make more perceptual errors such as reporting scrambled images as 
real images, possibly more so when the images are further suppressed from conscious 
perception. 2) PD patients with self-reported hallucinations will show increased intra-
individual variability in their task performance and 3) Perceptual error scores (PES) and 
intra-individual variability (CVRT) are associated with impaired functional connectivity 




2.2. Materials and Methods 
2.2.1. Participants 
Thirty-two patients with Parkinson’s disease (16 PD patients without self-reported 
hallucinations (PD-nonVH) and 16 with self-reported hallucinations (PD-VH)) and 25 
healthy age matched controls without a history of neurological or psychiatric diseases 
(assessed via questionnaire) were recruited. Exclusion criteria were moderate to severe 
general cognitive impairment/dementia (Mini Mental State Examination (MMSE) score < 
26), visual acuity below 80% (corrected with glasses as necessary) and psychiatric 
disorders other than minor depression. We matched the groups based on demographic 
variables such as age, gender and years of post-secondary education (Table 2.1.). 
Diagnosis of idiopathic Parkinson’s disease was made according to the UK Parkinson’s 
Disease Society Brain Bank criteria by experienced neurologists. The study was 
approved by the medical ethics committees of the University Medical Center 
Goettingen, Germany.  
Healthy controls and PD patients as a whole group did not differ in age (p = 0.17), 
gender (p = 0.48), education levels ranging from 0 (elementary school not finished) to 5 
(PhD) (p = 0.59) and years of post-secondary education (p = 0.76). Mann-Whitney-Test 
was used for measurements which violated the normality assumption. Compared to 
healthy controls PD patients tended to have lower MMSE scores (p = 0.06). Consistent 
with previous research PD patients had increased Beck’s Depression Inventory (BDI) 
scores (p = 0.00005) (Kritzinger et al., 2015) and lower contrast sensitivity (p = 0.009) 
(Meppelink et al., 2009)  compared to healthy controls.  
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PD-VH and PD-nonVH did not differ in age (p = 0.89), gender (p = 0.69), education 
levels (p = 0.76), years of post-secondary education (p = 0.47), MMSE scores (p = 
0.25), depression (BDI) scores (p = 0.45), contrast sensitivity (U = 86, p = 0.11) and 
Hoehn & Yahr stage (p = 0.10). Consistent with co-morbidity studies, PD-VH as 
compared to PD-nonVH patients had significantly longer disease durations (p = 0.007) 
and higher levodopa-equivalent daily dose (LEDD) (p = 0.0004) (Gupta, Singh, Khwaja, 
& Mehndiratta, 2004)  (Table 2.1.).  
Table 2.1. Demographic and neuropsychological characteristics of volunteers that participated in 
the image recognition task 
  HC  
(n = 25) 
PD (all) 
(n = 32) 
PD-
nonVH  
(n = 16) 
PD-VH 
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3.53              
(2.17) 









28.31         
(1.35) 
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Mann-Whitney U test;  BDI, Beck’s, Depression Inventory; 
c
Chi-square -test;                     
HC,healthy controls;LEDD, levodopa-equivalent daily dose; MMSE, Mini Mental State 
Examination;  PD, Parkinson patients;  PD-nonVH, Parkinson patients without v isual 
hallucinations; PD-VH, Parkinson patients with v isual hallucinations ;                                                                
UM-PDHQ, University of  Miami Parkinson's disease Hallucinations Questionnaire;                                                                                                                                                                                                                                  
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UPDRS, Unified Parkinson’s Disease Rating Scale; †HC vs. PD p< 0.05; *PD-nonVH vs. 
PD-VH p< 0.05      
                  
Apart from 1 non-medicated PD-nonVH, all PD patients were tested under stable 
dopaminergic medication, 7 patients (4 PD-VH, 3 PD-nonVH) were taking 
antidepressants, and 4 were using opioids (2 PD-VH, 2 PD-nonVH). The levodopa-
equivalent daily dose (LEDD) was calculated for all patients, according to the formula 
described in the paper by Tomlinson (Tomlinson et al., 2010). In the PD-VH group, 44% 
(N = 7) reported visual hallucinations multiple times per day, 25% (N = 4) multiple times 
per week, and 31% (N = 5) less than weekly. PD-VH reported complex visual 
hallucinations such as people (63%), animals (50%), insects (25%), objects (38%) and 
simple visual hallucinations (6%). Five (31%) PD-VH also reported auditory 
hallucinations.  
A sample of 16 (10 PD-nonVH, 6 PD-VH) Parkinson patients and 19 age-matched 
healthy control subjects participated in a resting-state scan (~6 min), performed either 
on the same or one to eight days after the behavioral experiment. Demographic and 
clinical variables of the fMRI sample are shown in Supplementary Table S2.1. In short, 
HC and PD patients did not differ with respect to age (p = 0.66), education level (p = 
0.69), years of post-secondary education (p = 0.88), contrast sensitivity (p = 0.78). PD 
patients had higher depression (BDI) scores (p = 0.02) and tended to have lower 
cognitive (MMSE) scores (p = 0.06). 
2.2.2. Clinical Test Batteries  
Motor symptoms were assessed with the Unified Parkinson Disease Rating Scale 
(UPDRS), part III (Goetz et al., 2008). General cognitive performance was tested with 
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the Mini Mental State Examination (MMSE) (Folstein, Folstein, & McHugh, 1975). 
Participants filled in a self-report depression scale (Beck’s Depression Inventory, BDI) 
(Beck, Ward, Mendelson, Mock, & Erbaugh, 1961). Severity of hallucinations was 
assessed by a structured interview based on the hallucinations questionnaire 
(University of Miami Parkinson's disease Hallucinations Questionnaire (UM-PDHQ)) 
(Papapetropoulos et al., 2008). Close vision test was performed to assess visual acuity 
(Poster Werner Radler). Contrast sensitivity was evaluated with the Mars Letters Test 
(Mars Perceptrix Corporation, Chappaqua, NY, USA).  
2.2.3. Experimental Design and Procedures 
2.2.3.1. Control task with unmasked images at 100% luminance contrast  
Before the start of the main experiment, participants were presented with 20 car or face 
images at 100% contrast. Subjects were instructed to press a pre-assigned button 
according to picture category. Maximal response time was 12 seconds. 
2.2.3.2. Main perceptual task   
Participants were sitting in a dimly lit room in front of an LCD monitor. Target stimuli 
consisted of photographs of faces (Ekman & Friesen, 1976), cars 
(http://vision.caltech.edu/archive.html) or their scrambled versions, presented in a 




Figure 2.1. Task design and trial structure. A) Example images of face, car and scrambled images 
used in the experiments. Trial structure B) non-CFS and C) CFS condition. 
 
Each trial started with the presentation of a central fixation cross, followed by the onset 
of the target image 600 ms later. Subjects were asked to maintain central fixation and to 
avoid eye blinks throughout the trial. Image luminance contrast was continuously 
stepped up over 10 seconds. Subjects were instructed to press a pre-assigned button 
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as quickly as possible when they detected a target image and to not press any button 
when the image category was not recognized or when a scrambled image was shown. A 
trial ended either after the response was given, or at 12 seconds after image onset 
(Figure 2.1B-C).  
We created a ‘visible’ (Figure 2.1B) and an ‘invisible’ condition (Figure 2.1C). For the 
‘invisible’ condition we used continuous flash suppression (CFS), designed to suppress 
the images from consciousness for several seconds via the presentation of high 
contrast and rapidly changing Mondrian patterns to the eye opposite of the target image 
(Tsuchiya & Koch, 2005) (Figure 2.1C). Non-CFS and CFS trials were presented in a 
pseudorandomized order. Since the CFS condition did not provide additional insights 
into differences between hallucinating and non-hallucinating PD patients (i.e. group 
effects were smaller)  we primarily focus the presentation of the results on the non-CFS 
condition as depicted in Figure 2.1B. The non-CFS condition consisted of 100-120 trials 
per subject (1/3 of each image category).  
2.3.3. Resting state image acquisition 
Subjects were instructed to stay awake with their eyes closed and not to think of 
anything in particular during the resting-state scan (~ 6 min.) fMRI data were acquired 
using a 3 Tesla MR system (Magnetom TIM Trio, Siemens Healthcare, Erlangen, 
Germany) with a 32-channel phased-array head coil. fMRI resting-state experiments 
were performed using the 2D multiband gradient-echo planar imaging sequence from 
the Center for Magnetic Resonance Research, University of Minnesota (Moeller et al., 
2010; Setsompop et al., 2012) with T2*-weighting at 3 x 3 mm² in-plane resolution, 
oriented parallel to the AC-PC plane (TR: 1800 ms, TE: 30 ms, flip angle: 70°, 34 slices 
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of 3 mm thickness with 20 % inter-slice gap, field-of-view: 192 mm x 192 mm, matrix 
size: 64 x 64, multiband acceleration factor 3, 194 whole-brain volumes per functional 
run). 
2.2.4.  Analyses 
2.2.4.1. Demographic, clinical and behavioral statistical data analysis 
Data analysis was performed using custom written scripts in MATLAB R2012b and 
SPSS (version 24; SPSS, Inc., Chicago, IL). Univariate ANOVA and t-tests were used 
to compare age, UPDRS-III and LEDD. Chi-square test was used to compare gender. 
Non-parametric Mann-Whitney U-Tests were used to compare years of post-secondary 
education, education level, years of disease duration, Hoehn and Yahr stage, BDI and 
MMSE scores, visual acuity and contrast perception between groups. 
Unless otherwise noted, behavioral analysis was performed by a mixed ANOVA with the 
within-subject factor “Category” (faces vs. cars) and the between-subject factor “Group”. 
Two types of ANOVAs were calculated: 1) ANOVA with the “Group” factor HC vs. all PD 
patients (PD-VH + PD-nonVH) together (in the following “ANOVA_1”). 2) To investigate 
behavioral markers that are specific for VH in PD we used a separate ANOVA with the 
“Group” factor PD-nonVH vs. PD-VH (in the following “ANOVA_2”).  
The description of the results will focus on main and interaction effects of "Group", 
additional ANOVA results are provided in (Table 2.3., Supplementary Table S2.2.). 
Bonferroni correction was applied for multiple comparisons of the main effect of factor 
“Group” in  ANOVA_1 and ANOVA_2, resulting in a significance threshold of p < 0.025. 
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Additional control analyses 
When there was a significant difference between PD-VH and PD-nonVH we performed 
an additional control analysis by an ANCOVA with levodopa daily dose and disease 
duration as covariates. The co-variate analyses were performed since disease duration 
and LEDD significantly differed between PD-nonVH and PD-VH. 
To exclude possible influences of individual values on the group differences, reliability of 
the results for the main outcome measures, perceptual error score and coefficient of 
recognition time variability, was tested applying the jackknife procedure by repeating the 
patient comparison by systematically removing one sample and re-calculating the mean 
(Wilke, 2012).  
2.2.4.2. Key performance measures 
Performance parameters were calculated separately for each image category (faces or 
cars).  
Image Recognition Performance  
I) Proportion Correct Recognition: Proportion Correct Categorization (face reported as a 
face and car reported as car) divided by the overall number of image presentations 
including missed responses; II) Proportion Misses: Trials in which a face or a car was 
presented but the subject did not provide a button response divided by the overall 
number of image presentations; III) Proportion erroneous face or car reports in 
scrambled images; IV) Perceptual error score (PES): Proportion errors consisting of 
category confusions (face reported as car and vice versa), misses and false real image 
detection in scrambled images.  
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Recognition times: means and intra-individual variability  
Mean recognition times (RT) denote the time between image onset and button 
response. Only correct responses were used to compute mean RT. Coefficient of 
recognition time variability (CVRT) was calculated by dividing the standard deviation of 
individual recognition times for a given condition and image category (car, face) by the 
individual mean of recognition times (standard deviation/mean) (Flehmig, Steinborn, 
Langner, Scholz, & Westhoff, 2007).  
2.2.4.3. Resting state functional connectivity 
Preprocessing 
All fMRI data processing was performed using the CONN Toolbox 
(www.nitrc.org/projects/conn, RRID: SCR_009550). For each subject’s data set, 
preprocessing steps included: functional motion estimation and correction, functional 
and structural data translations to center (0,0,0 coordinates), functional data slice-timing 
correction, functional ART-based outlier detection, direct, simultaneous gray 
matter/white matter/cerebral spinal fluid (GM/WM/CSF, respectively) segmentation and 
MNI normalization applied to functional and structural data separately, and 6 mm full-
width-at-half-maximum-kernel Gaussian smoothing. The following denoising steps were 
implemented: linear regression of confounding effects, including GM, WM, and CSF 
signals (CompCor method) (Behzadi, Restom, Liau, & Liu, 2007), realignment 
parameters and their first derivatives, ART-detected outlier volumes, and the effect of 
the resting task (temporal filter reducing weight of initial 10 scans in the run). Linear 
detrending was applied prior to a 0.008 - 0.09 Hz bandpass filter.  
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Statistical analyses: voxelwise volume analysis 
Group-level independent component analysis (ICA) was applied to the whole sample of 
combined patients and healthy controls in order to spatially define resting state 
networks (RSNs). Data dimensions were reduced through retaining 40 components of 
an initial principle component analysis of the temporally-concatenated runs for the 
whole group, followed by 20-component ICA. Of the 20 resulting components, eight 
were visually identified as RSNs of interest as previous imaging studies reported 
impairments in frontal, parietal and visual brain regions (Baggio et al., 2015; Prell, 
2018): default mode (DMN), dorsal attention (DAN), left and right fronto-parietal (lFP, 
rFP, respectively), medial and lateral visual (medVIS and latVIS, respectively), 
somatomotor (SMN), and salience (SAL) (for more detailed network description see 
Table 2.2.). Dual regression was applied to the group ICA results using all components 
generated from the initial analysis, resulting in subject-level beta maps of all 
components, including the RSNs of interest (Beckmann, Mackay, Filippini, & Smith, 
2009). For second-level statistical tests, comparisons were made with network-level 
beta averages against behavioral statistics as well as equivalent full-volume voxelwise 
tests that included behavioral covariates. To generate masks for subject-level RSN 
averages, for each of the selected components, a one-sample t-test was performed 
using all subjects, and an uncorrected voxel-level p = 0.05 and FWE-corrected cluster-
level p = 0.05 were applied. Threshold values were chosen liberally to include each 
RSN without excessive overlap among networks. Figure 2.2. shows the resting state 
network maps from group-level ANOVA results of the ICA analysis. Resulting 
thresholded maps were binarized to be used as RSN masks to summarize within- and 
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between-network functional connectivity for group-level statistics. For within- and 
between-network functional connectivity measures, for every subject, each group-level 
RSN mask was applied to each network volume map to extract average beta values. 
Subject-level within- and between-network average beta values were used in further 
analysis with behavioral data in SPSS. 
 
Figure 2.2. ICA Resting state networks. Spatial maps representing the eight resting state networks of 
interest, generated through ANOVAs on each chosen ICA result, displaying the simple main effect of 
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each RSN component for all subjects (left), healthy controls (center), and all PD patients (right; for all 
maps: uncorrected voxel-level p <0.05, FWE-corrected cluster p <0.05). 
 
Table 2.2. Overview of Networks of Interest. 
Network Brain areas 
Dorsal Attention  Precuneus, Inferior and Superior Parietal Lobule, Pre- and Postcentral Gyrus 
Cuneus, Paracentral Lobule, Middle and Superior Occipital Gyrus 
Middle and Superior Frontal Gyrus, Fusiform Gyrus, Inferior Temporal Gyrus 
Default Mode Precuneus, Posterior Cingulate, Inferior, Middle and Superior Temporal Gyrus 
Cuneus, Parahippocampal Gyrus, Angular Gyrus, Superior Occipital Gyrus 
Inferior Parietal Lobule, Anterior Cingulate, Fusiform Gyrus, Right Insula 
Middle and Superior Frontal Gyrus 
Salience Medial and Superior Frontal Gyrus, Cingulate Gyrus, Anterior Cingulate 
Precuneus, Superior Temporal, Insula, Pre- and Postcentral Gyrus,  
Lingual Gyrus, Cuneus, Middle Occipital Gyrus, Lentiform Nucleus 
Inferior Parietal Lobule 
Left fronto-parietal  Left Inferior, Middle and Superior Frontal Gyrus, Left Precentral Gyrus 
Left Middle and Superior Temporal Gyrus, Left Inferior and Superior Parietal 
Lobule, Left Precuneus, Left Supramarginal Gyrus 
Right fronto-
parietal 
Right Inferior, Middle and Superior Frontal Gyrus,Right Precentral Gyrus 
Right Inferior and Superior Parietal Lobule, Right Precuneus 
Right Angular Gyrus, Right Superior Temporal Gyrus 
Somatomotor Medial and Superior Frontal Gyrus, Post- and Precentral Gyrus 
Paracentral Lobule 
Visual lateral Inferior, Middle and Superior Occipital Gyrus, Cuneus, Fusiform Gyrus 
Visual medial Cuneus, Lingual Gyrus, Precuneus 
 
2.2.4.4. Group differences in Resting state networks 
To investigate differences between HC and PD patients we performed full-volume 
voxelwise comparisons for the eight networks of interest (default mode, dorsal attention, 
salience, right and left fronto-parietal, somatomotor, visual medial and lateral). To test 
differences of within network connectivity, averages of the eight networks were 
submitted to a univariate ANOVA, with “Group” (HC and PD) as a between subject 
factor. Given the limited sample size (PD-nonVH = 10, PD-VH = 6) we did not compare 
the PD patient subgroups. 
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2.2.4.5. Correlation between Resting state functional connectivity and Perceptual 
Error Score (PES) and Coefficient of intra-individual variability (CVRT)  
In order to investigate the relationship between functional connectivity averages and the 
behavioral markers PES and CVRT, we performed for the PD group Spearman’s rho 
correlations. Partial correlations of PD patients including disease duration and daily 
levodopa dose (LEDD) were used as control variables (Baggio et al., 2015; Shine, 
Keogh, et al., 2015). Given the limited subsample size, we did not separate the PD 
patient groups when correlating the functional connectivity estimates with the main 
outcomes measures. PES scores violated the assumptions of linear correlation and 
were thus transformed using logarithmic transformation (log (PES + 1)) (Bartlett, 1947; 




2.3. Results   
2.3.1. Correct image recognition in the control task  
In the control task in which either face or car images were presented at 100% contrast, 
the proportion of correctly categorized face and car images did not significantly differ 
between healthy controls and PD patients (ANOVA_1: F(1,55) = 0.0001, p = 0.99) nor 
between the two PD patient groups (ANOVA_2: PD-nonVH vs. PD-VH: (F(1,30) = 0, p = 
1). In all three groups the proportion correct image recognition in the control task was 
above 95% (HC: 97.2%, PD-nonVH: 97.19%, PD-VH: 97.19%) verifying that all groups 
were able to perform the task.  
2.3.2. Correct image recognition in the main task (non-CFS) 
Figure 2.3A shows that HC correctly recognized the images in 99% while PD patients 
reached on average only 90%. Accordingly, the ANOVA_1 showed a main group effect 
between HC and PD patients (F(1,55) = 9.52, p = 0.003).        
The separate comparison between the two PD patient groups showed that PD-VH 
patients recognized fewer images correctly than the PD-nonVH, expressed as a 
significant group effect in the ANOVA_2, (ANOVA_2: F(1,30) = 11.42, p = 0.002) 
(Figure 2.3A, right column). Given the larger levodopa daily dose (LEDD) and longer 
disease durations of PD-VH patients as compared to PD-nonVH, we conducted an 
additional analysis including and disease duration as covariates in the ANCOVA. This 
control analysis did not yield a significant difference in respect with correct image 
recognition between the two PD groups (F(1,30) = 1.96, p = 0.17), indicating that 
dopaminergic medication and/or disease duration might be confounds explaining the 
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lower recognition performance in PD-VH patients. 
With respect to misses (i.e. no indicated image recognition within the 12 seconds of a 
trial), PD patients as a group had a non-significant tendency for more misses (Figure 
2.3B). The comparison between the two PD groups yielded a tendency for a higher 
proportion of misses in the PD-VH group (ANOVA_2: PD-VH: 9%, PD-nonVH: 0.16%, 
(main effect of “Group”: F(1,30) =  5.12, p = 0.03), albeit not passing the Bonferroni 
correction (p < 0.025). 




Figure 2.3. Proportion Correct Image Recognition and Misses. (A) Mean proportion of correct image 
recognition of faces and cars. (left) HC (N = 25) vs. PD (N = 32) (right) PD-nonVH (N = 16) vs. PD-VH (N 
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= 16) (B) Mean proportion of missed faces and cars. (left) HC (N = 25) vs. PD (N = 32) (right) PD-nonVH 
(N = 16) vs. PD-VH (N = 16). In (A) and (B) ** denotes a significant group difference, p < 0.005 and # 
denotes p < 0.05 without Bonferroni correction as assessed by ANOVA_1 (HC vs. PD) and ANOVA_2 
(PD_nonVH vs. PD_VH). Error bars denote S.E.M. across subjects. 
 
2.3.3. Erroneous detection of real life images in scrambled images (non-CFS) 
Figure 2.4. shows that PD patients tended to report real images in scrambled images 
more often than HC (HC: 6%, PD: 20%, ANOVA_1: F(1,55 = 4.86, p = 0.03, n.s. after 
Bonferroni correction). The ANOVA comparing PD-nonVH with PD-VH revealed that 
this effect was mainly driven by the PD-VH, who reported a real image in 32% of trials 
as compared to PD-nonVH with only 8% (F(1,30) = 7.56, p = 0.01) (Figure 2.4., right 
column). The higher proportion of false image reports in the PD-VH group is also 
supported by a significant effect of “Group” (F(1,28) = 12.75, p = 0.001) in the ANCOVA 




Figure 2.4. Erroneous Image Recognition in Scrambled Images. Mean proportion of erroneous image 
recognition in scrambled images. (left) HC (N = 25) vs. PD (N = 32) (right) PD-nonVH (N = 16) vs. PD-VH 
(N = 16) * denotes a significant group difference (Bonferroni correction, p < 0.025) as assessed by 
ANOVA_2 (PD_nonVH vs. PD_VH). # denotes a significant group difference (without Bonferroni 
correction, p < 0.05) as assessed by ANOVA_1 (HC vs. PD). Error bars denote S.E.M. across subjects. 
 
2.3.4. Perceptual Error Score (non-CFS) 
Assuming that a combined sum score of different image recognition errors is more 
robust in clinical studies than the separate ones, we computed a sum perceptual error 
score (PES) of category confusion, misses and false real image detection in scrambled 
images. As illustrated in Figure 2.5., PD patients (14%) had higher PES scores 
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compared to HC (3%) which is also revealed by the main effect of “Group” in the 
ANOVA (ANOVA_1: F(1,55) = 9.81, p = 0.003).  
     
Figure 2.5. Perceptual Error Score (PES). Mean Perceptual Error Score, separated by subject group.  
(left) HC (N = 25) vs. PD (N = 32) (right) PD-nonVH (N = 16) vs. PD-VH (N = 16). ** denotes a significant 
group difference, p < 0.005 by ANOVA_1 (HC vs. PD) and ANOVA_2 (PD-nonVH vs. PD-VH). Error bars 
denote S.E.M. across subjects. 
 
 
Figure 2.5. (right column) shows that this effect is led by the higher PES scores in PD-
VH (24%) compared to PD-nonVH (5%), expressed also by the main effect of “Group” in 
the ANOVA comparing PD-nonVH and PD-VH (ANOVA_2: F(1,30) = 17.16, p = 
0.0003). The ANCOVA comparing PD-nonVH with PD-VH that included levodopa daily 
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dose and disease duration as covariates showed a robust effect, with a significant effect 
of “Group” (F(1,28) = 13.88, p = 0.001). This suggests that the differences in PES 
cannot be explained only by the differences in LEDD and disease duration. 
To further demonstrate the stability of the group difference in PES between PD-VH and 
PD-nonVH, a Jackknife procedure was applied. Systematically leaving out one subject 
from the analysis and recomputing the ANOVA_2 always resulted in significant main 
effects of “Group” (all p values were in the range [0.0001 – 0.0005]). Finally, the 
calculation of PES cut-off scores underlines its potential to discriminate between PD-
nonVH and PD-VH. Specifically, 11 PD-VH patients (69%) scored above the PES cut off 
score of 0.15 (average PES score of HC + 1.5 SD of HC) as compared to only 1 PD-
nonVH (6%) and 2 HC (8%), showing its potential discriminative value in detecting 
hallucinating PD patients.  
2.3.5. Mean Recognition times (non-CFS) 
As expected from previous studies (e.g. (Meppelink et al., 2008), PD patients were 
slower in image recognition than HC (F(1,55) = 8.87, p = 0.004). (Supplementary 
Table S2.2.). Comparing the two PD groups, PD-VH had longer mean recognition times 
than PD-nonVH (F(1,30) = 13.58, p = 0.001) (Table 2.3.). When LEDD and disease 
duration were included in the ANCOVA, the two patient groups did not significantly differ 
in respect to mean recognition times (F(1,28) = 2.78, p = 0.11), indicating that the LEDD 





2.3.6. Intra-individual variability of recognition times (non-CFS) 
So far we considered only mean recognition times. However, intra-individual variability 
is increased in medicated and unmedicated PD patients and is discussed as a possible 
marker of ensuing cognitive dysfunction in PD (Camicioli et al., 2008; de Frias, Dixon, 
Fisher, & Camicioli, 2007). In the next step we assessed the intra-individual variability of 
RTs expressed as the coefficient of individual recognition time variability across trials 
(CVRT) (MacDonald et al., 2009). As shown in Figure 6, the CVRT of the PD patients as 
a whole group, did not differ from the HC (ANOVA_1, F(1,55) = 0.47, p = 0.5).  
The direct comparison between the two PD groups showed a larger RT variability for 
faces and cars in the PD-VH (0.23) as compared to PD-nonVH (0.19), which is also 





Figure 2.6. Coefficient of Recognition Time variability. Average of individual variability in RT (CVRT = 
individual standard deviation of RT divided by the individual RT mean). (left) No significant group 
differences between HC and PD as analyzed by ANOVA are shown. (right) PD-nonVH vs. PD-VH, * 
denotes a significant group difference, Bonferroni corrected for multiple comparisons p < 0.0025 (black 




The difference between PD-VH and PD-nonVH remained significant when including 
disease duration and LEDD as covariates in the ANCOVA (F(1,28)= 4.34, p= 0.047) 
(Supplementary Table S2.3).  
Supplementary Figures S2.1. and S2.2. illustrate that this effect cannot be explained 
by outliers or by an increase in RT during the experiment. To ensure the stability of this 
finding we performed the Jackknife procedure which showed reliability of the CVRT 
group differences of p-values in the significant range [0.005; 0.01].  
Table 2.3. ANOVA_2: Repeated Measures mixed ANOVA with the factors Category, Group and 
interaction effects for Parkinson patients without visual hallucinations (PD-nonVH) and Parkinson 

















































PD-nonVH, Parkinson patients without visual hallucinations (N  = 16);                                                                                                       
PD-VH, Parkinson patients with visual hallucinations (N =  16)                                                                                                           
RT, Recognition times; CVRT, Mean individual variability coefficients (individual SD/individual mean) of 
recognition times Between-subject factor: Group: PD-nonVH vs. PD-VH Within-subject factor: Category: 
faces vs. car (except for PES and Proportion erroneous recognition in scrambled images)                                                                                                                                                                
** p < 0.005 Significant between and within main and interaction effects (Bonferroni correction * p < 
0.025) # p < 0.05 Significant effects without Bonferroni correction. 
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2.3.7. CFS condition: all perceptual measures 
To investigate how perceptual awareness might contribute to the sensitivity of 
behavioral markers of VH, we also assessed perceptual errors, RT and CVRT in the 
‘invisible’ condition created by using CFS (Tsuchiya & Koch, 2005) (Supplementary 
Table S2.4). In the CFS condition, healthy controls and PD patients did not differ in the 
proportion correct recognition (F(1,55) = 2.81, p = 0.10), proportion missed responses 
(F(1,55) = 0.93, p = 0.34), proportion misperceived scrambled images (F(1,55) = 1.21, p 
= 0.28) and or PES (F(1,55) = 3.33, p = 0.07) (ANOVA_1, Supplementary Table S2.5). 
Comparable to the non-CFS condition, PD-VH patients made more image recognition 
errors (F(1,30) = 8.18, p = 0.008), and missed more responses than the PD-nonVH 
(F(1,30) = 7.01, p = 0.01) (ANOVA_2, Supplementary Table S2.6). These differences 
were not significant in the ANCOVA model with LEDD and disease duration as 
covariates (p > 0.07) (Supplementary Table S2.7). PD-VH had a higher perceptual 
error score (ANOVA_2, F(1,30) = 8.27, p = 0.007; ANCOVA, F(1,28) = 7.66, p = 0.01) 
(ANOVA_2, Supplementary Table S2.6, ANCOVA, Supplementary Table S2.7). PD 
patients did not need more time to respond and did not differ in respect to variability of 
RT in comparison to HC (p > 0.57) (ANOVA_1, Supplementary Table S2.5). In 
contrast to the non-CFS condition here was no difference in RT and variability of RT 
between PD-nonVH and PD-VH (p > 0.19) (ANOVA_2, Supplementary Table S2.6). 
Most likely, the lack of group RT effects in the CFS condition is due to the fact that 
recognition times in the CFS condition vary strongly across trials in all groups due to the 
additional perceptual suppression component. 
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2.3.8. Resting state  
We first tested group differences of network functional connectivity estimates of the 
eight networks of interest using univariate ANOVAs. This analysis showed no significant 
differences between HC and PD patients (default mode: F(1,33) = 1.94, p = 0.17, dorsal 
attention: F(1,33) = 2.15, p = 0.15, Salience: F(1,33) = 1.19, p = 0.28, left fronto-parietal: 
F(1,33) = 0.03, p = 0.86, right fronto-parietal: F(1,33) = 1.78, p = 0.19, somatomotor: 
F(1,33) = 3.89, p = 0.06, Visual medial: F(1,33) = 0.16, p = 0.69, Visual lateral: F(1,33) = 
0.02, p = 0.9). Given that we had a smaller subsample of PD patients, (10 PD-nonVH 
and 6 PD-VH,), we did not compare the different PD patient groups. Functional 
connectivity maps of HC and PD patients are presented in Figure 2.2. 
2.3.8. Correlation of Resting state functional connectivity and Perceptual Error 
score (PES), intra-individual variability of recognition times (CVRT)  
Spearman’s rho correlations were used to investigate the relationship between PES, 
CVRT and resting state network functional connectivity in the PD group. To ensure 
reliability of our findings we also performed partial correlations including disease 
duration and LEDD as control variables. The partial correlations for all networks of 
interest are summarized in Supplementary Table S2.8. 
Among the PD patients, perceptual error scores (log (PES + 1) were negatively 
correlated with functional connectivity between the left fronto-parietal network and the 
somatomotor network (rs = -0.56, p = 0.03)), which did not remain stable after 
performing partial correlations including LEDD and disease duration (r = -0.12, p = 
0.72). PES was also negatively correlated with functional connectivity between the 
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dorsal attention network and salience network (rs = -0.50, p = 0.049) which remained 
stable after performing partial correlations including LEDD and disease duration (r = -
0.54, p = 0.047). (Figure 2.7A, see Supplementary Table S2.8, for values of all 
networks). Among the PD patients, CVRT was negatively correlated to functional 
connectivity between the right fronto-parietal network and default mode network (rs = -
0.54, p = 0.03) which did not remain stable including LEDD and disease duration as 
control variables (r = -0.53, p = 0.053). CVRT was also negatively correlated with 
functional connectivity between somatomotor network and right fronto-parietal network 
(rs = -0.51, p = 0.044) which remained stable after performing partial correlations using 
LEDD and disease duration as control variables (r = -0.55, p = 0.041) (Figure 2.7B, 
Supplementary Table S2.8).  
Figure 2.7. Within- and between-network connectivity associated with perceptual error score 
(PES) and individual variability of RT. (A) Scatter plot of logarithmic transformation of the PES on the x 
axis and connectivity of the dorsal attention network to salience networks on the y axis of PD patients (N 
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= 16).  (B) Scatter plot of CVRT on the x axis and connectivity of somatomotor (SMN) to right fronto-
parietal networks on the y axis (N = 16). Blue dots show the individual values of PD-nonVH (N = 10) and 





We showed that perceptual errors and elevated intra-individual behavioral variability 
characterize PD patients with self-reported hallucinations compared to PD patients not 
reporting VH. We showed that these behavioral measures are associated with 
functional connectivity changes in overlapping, but slightly different neural networks: 
higher PES correlated with lower functional connectivity between dorsal attention 
network and salience network, while higher intra-subject variability in RT correlated with 
lower functional connectivity between somatomotor and right fronto-parietal networks. 
2.4.1. Comparison with previous findings on misperceptions in PD-VH patients  
In accordance with previous studies, PD-VH patients exhibited lower rates of correct 
image recognition and reported real images in scrambled images more often than PD-
nonVH (Meppelink et al., 2008; Ramirez-Ruiz et al., 2007; Shine et al., 2012). It remains 
to be investigated which score is more sensitive for the identification of hallucinating 
patients and which can serve best to identify patients experiencing or being at risk to 
develop hallucinations. Consistent with previous research we found a negative 
correlation between misperceptions and functional connectivity between dorsal attention 
network and the salience network, (Shine, Keogh, et al., 2015). The salience network is 
related to the degree of personal salience in the cognitive, emotional or homeostatic 
domain and interoceptive-autonomic processing (Seeley et al., 2007). Distortion in 
attentional processes might be a common mechanism for the development of visual 
hallucinations given that attentional deficits have also been shown in hallucinating 
patients suffering from Charles Bonnet syndrome and dementia (Graham et al., 2011; 
Makin et al., 2013). 
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2.4.2. Intra-individual variability in recognition times  
PD-VH patients showed higher intra-individual variability in recognition times than PD-
nonVH, which to our knowledge has not been reported before. Performance fluctuations 
are problematic for the development of objective measures for VH based on mean 
performance (MacDonald et al., 2009). At the same time, intra-individual variability 
appears to be a promising variable as previous research indicates that trial-by-trial 
fluctuations in RT correlate negatively with cognitive performance and can even serve 
as a sensitive predictor for age-related cognitive decline (Bielak, Hultsch, Strauss, 
MacDonald, & Hunter, 2010; MacDonald, Nyberg, & Bäckman, 2006), incipient 
dementia in PD (de Frias et al., 2012) and identification of individuals at risk to develop 
hallucinations such as persons at risk for schizophrenia (Shin et al., 2013). In healthy 
aging populations, larger intra-individual variability has been linked to attentional lapses 
(Bunce, Warr, & Cochrane, 1993) and deficits in executive control (West, Murphy, 
Armilio, Craik, & Stuss, 2002). Since previous studies reported a strong link between 
visual hallucinations in PD and deficits in attentional and executive processes (Barnes, 
Boubert, Harris, Lee, & David, 2003; Gallagher et al., 2011; Hall et al., 2016; Meppelink 
et al., 2008), this functional interpretation is plausible (Muller et al., 2014; Shine et al., 
2014). Concerning neural correlates of performance variability, the most consistent 
correlation with increased intra-individual variability in healthy elderly and other patient 
groups have been found with structural and functional alterations of prefrontal cortices 
(MacDonald et al., 2006; Murtha, Cismaru, Waechter, & Chertkow, 2002) and 
alterations in DMN and attentional networks (Kelly, Uddin, Biswal, Castellanos, & 
Milham, 2008), which both include prefrontal regions. We found that PD patients with 
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higher intra-individual variability show reduced functional connectivity between 
somatomotor and right fronto-parietal networks. Previous research reported 
hyperconnectivity of fronto-parietal regions in hallucinating PD patients compared to 
non-hallucinating PD patients (Franciotti et al., 2015; Yao et al., 2014). The 
sensorimotor network is important for voluntary movements and shows deviant 
functional connectivity in PD (Biswal, Yetkin, Haughton, & Hyde, 1995). However, 
exploratory analyses of our data show that the severity of the motor symptoms 
measured with the UPDRS score III was not related to functional connectivity between 
SMN and right fronto-parietal network using LEDD and disease duration as covariates, 
indicating that the correlation between CVRT and functional connectivity between SMN 
and right fronto-parietal network is not driven by movement disabilities in PD (r = 0.17, p 
= 0.62). Hypoconnectivity within the somatosensory and between fronto-parietal and 
ventral attentional network has also been reported in schizophrenia which indicates their 
possible involvement in hallucinations (Dong, Wang, Chang, Luo, & Yao, 2018). 
Furthermore, during working memory maintenance patients with mild cognitive 
impairment show hypoactivation of right fronto-parietal regions (Melrose et al., 2018) 
indicating its influence in cognitive decline. Increased intra-individual behavioral 
fluctuations were reported in multiple other diseases such as schizophrenia, autism, 
attention deficit hyperactivity disorder (ADHD) as well as in aging populations exhibiting 
cognitive decline (Dinstein, Heeger, & Behrmann, 2015; MacDonald, Li, & Bäckman, 
2009). Thus, the intra-individual variability observed in our task together with the 
hypoconnectivity of the somatomotor and fronto-parietal networks might be useful to 
predict cognitive changes in PD patients rather than the occurrence of visual 
64 
 
hallucinations itself.   
2.4.3. Limitations  
One limitation is that we cannot be sure about the type of misperceptions participants 
experienced during the presentation of scrambled images. As such there is a tradeoff 
between verbally reporting patients providing more insight into phenomenology, and 
trial-based measures offering the opportunity to collect many trials of the same type. 
Another limitation of the current study is the relatively small sample size of the 
demographically matched PD patients and the small subsample participating in the 
resting state. For this reason the correlational analyses of resting state functional 
connectivity need to be interpreted with caution as the subsample did not provide 
sufficient power to apply Bonferroni correction with confidence about possible negative 
results.  Clearly, a study with a larger PD sample where it is not only possible to control, 
but to match the patients for clinical variables such as LEDD and disease duration, is 
warranted. Albeit we tested for visual impairments and general cognitive state, we did 
not include assessments of attentional or executive functions in our study. Future 
studies would also profit from the identification of different phenotypes in cognition and 
attention such as memory, sustained, selective, alternating and divided attention. 
Moreover, differences in phenotype profiles of different clinical groups such as patients 
with mild cognitive impairments and different types of dementia would also be helpful to 




Armstrong, R. A. (2011). Visual Symptoms in Parkinson’s Disease. Parkinson’s 
Disease, 2011. https://doi.org/10.4061/2011/908306 
Baggio, H. C., Segura, B., Sala-Llonch, R., Marti, M. J., Valldeoriola, F., Compta, Y., … 
Junqué, C. (2015). Cognitive impairment and resting-state network connectivity 
in Parkinson’s disease. Human Brain Mapping, 36(1), 199–212. 
https://doi.org/10.1002/hbm.22622 
Bartlett, M. S. (1947). The Use of Transformations. Biometrics, 3(1), 39–52. 
https://doi.org/10.2307/3001536 
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory 
for measuring depression. Archives of General Psychiatry, 4, 561–571. 
Beckmann, C. F., Mackay, C. E., Filippini, N., & Smith, S. M. (2009). Group comparison 
of resting-state FMRI data using multi-subject ICA and dual regression. 
Neuroimage, 47(Suppl 1), S148. 
Behzadi, Y., Restom, K., Liau, J., & Liu, T. T. (2007). A component based noise 
correction method (CompCor) for BOLD and perfusion based fMRI. NeuroImage, 
37(1), 90–101. https://doi.org/10.1016/j.neuroimage.2007.04.042 
Bielak, A. A., Hultsch, D. F., Strauss, E., MacDonald, S. W., & Hunter, M. A. (2010). 
Intraindividual variability in reaction time predicts cognitive outcomes 5 years 
later. Neuropsychology, 24(6), 731. 
Camicioli, R. M., Wieler, M., de Frias, C. M., & Martin, W. R. W. (2008). Early, untreated 
Parkinson’s disease patients show reaction time variability. Neuroscience 
Letters, 441(1), 77–80. https://doi.org/10.1016/j.neulet.2008.06.004 
66 
 
Collerton, D., Perry, E., & McKeith, I. (2005). Why people see things that are not there: 
a novel Perception and Attention Deficit model for recurrent complex visual 
hallucinations. The Behavioral and Brain Sciences, 28(6), 737–757; discussion 
757-794. https://doi.org/10.1017/S0140525X05000130 
de Frias, C. M., Dixon, R. A., & Camicioli, R. (2012). Neurocognitive speed and 
inconsistency in Parkinson’s disease with and without incipient dementia: an 18-
month prospective cohort study. Journal of the International Neuropsychological 
Society: JINS, 18(4), 764–772. https://doi.org/10.1017/S1355617712000422 
de Frias, C. M., Dixon, R. A., Fisher, N., & Camicioli, R. (2007). Intraindividual variability 
in neurocognitive speed: a comparison of Parkinson’s disease and normal older 
adults. Neuropsychologia, 45(11), 2499–2507. 
https://doi.org/10.1016/j.neuropsychologia.2007.03.022 
Diederich, N. J., Fénelon, G., Stebbins, G., & Goetz, C. G. (2009). Hallucinations in 
Parkinson disease. Nature Reviews. Neurology, 5(6), 331–342. 
https://doi.org/10.1038/nrneurol.2009.62 
Ekman, P., & Friesen, W. V. (1976). Pictures of Facial Affect. Palo Alto.CA.Colsulting 
Psychologists Press. 
Fassbender, C., Lesh, T. A., Ursu, S., & Salo, R. (2015). Reaction Time Variability and 
Related Brain Activity in Methamphetamine Psychosis. Biological Psychiatry, 
77(5), 465–474. https://doi.org/10.1016/j.biopsych.2014.07.028 
Fassbender, C., Scangos, K., Lesh, T. A., & Carter, C. S. (2014). RT distributional 
analysis of cognitive-control-related brain activity in first-episode schizophrenia. 
67 
 
Cognitive, Affective & Behavioral Neuroscience, 14(1), 175–188. 
https://doi.org/10.3758/s13415-014-0252-4 
Flehmig, H. C., Steinborn, M., Langner, R., Scholz, A., & Westhoff, K. (2007). Assessing 
intraindividual variability in sustained attention: reliability, relation to speed and 
accuracy, and practice effects. Psychology Science, 49(2), 132–149. 
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”. A practical 
method for grading the cognitive state of patients for the clinician. Journal of 
Psychiatric Research, 12(3), 189–198. 
Goetz, C.G., Tilley, B.C., Shaftman, S.R., Stebbins, G.T., Fahn, S., Martinez‐Martin, P.,
  Poewe, W., Sampaio, C., Stern, M.B., Dodel, R., Dubois, B., Holloway, R., 
 Jankovic, J., Kulisevsky, J., Lang, A.E., Lees, A., Leurgans, S., LeWitt, P.A., 
 Nyenhuis, D., Olanow, C.W., Rascol, O., Schrag, A., Teresi, J.A., Hilten, J.J. van,
  LaPelle, N., 2008. Movement Disorder Society-sponsored revision of the Unified 
 Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and 
 clinimetric testing results. Movement Disorders 23, 2129–2170. 
 https://doi.org/10.1002/mds.22340 
Graham, G., Dean, J., Mosimann, U. P., Colbourn, C., Dudley, R., Clarke, M., & 
Collerton, D. (2011). Specific attentional impairments and complex visual 
hallucinations in eye disease. International Journal of Geriatric Psychiatry, 26(3), 
263–267. https://doi.org/10.1002/gps.2522 
Gupta, M., Singh, G., Khwaja, G. A., & Mehndiratta, M. M. (2004). Hallucinations in 
Parkinson’s disease--a study of forty three patients. The Journal of the 
Association of Physicians of India, 52, 703–706. 
68 
 
Koerts, J., Borg, M. A. J. P., Meppelink, A. M., Leenders, K. L., van Beilen, M., & van 
Laar, T. (2010). Attentional and perceptual impairments in Parkinson’s disease 
with visual hallucinations. Parkinsonism & Related Disorders, 16(4), 270–274. 
https://doi.org/10.1016/j.parkreldis.2010.01.003 
Kritzinger, C., Vollstedt, E.-J., Hückelheim, K., Lorwin, A., Graf, J., Tunc, S., … Kasten, 
M. (2015). Qualitative Characteristics of Depression in Parkinson’s Patients and 
Controls. Behavioural Neurology, 2015, 961372. 
https://doi.org/10.1155/2015/961372 
MacDonald, S. W. S., Li, S.-C., & Bäckman, L. (2009). Neural underpinnings of within-
person variability in cognitive functioning. Psychology and Aging, 24(4), 792–808. 
https://doi.org/10.1037/a0017798 
MacDonald, S. W. S., Nyberg, L., & Bäckman, L. (2006). Intra-individual variability in 
behavior: links to brain structure, neurotransmission and neuronal activity. 
Trends in Neurosciences, 29(8), 474–480. 
https://doi.org/10.1016/j.tins.2006.06.011 
Makin, S. M., Redman, J., Mosimann, U. P., Dudley, R., Clarke, M. P., Colbourn, C., & 
Collerton, D. (2013). Complex visual hallucinations and attentional performance 
in eye disease and dementia: a test of the Perception and Attention Deficit 
model. International Journal of Geriatric Psychiatry, 28(12), 1232–1238. 
https://doi.org/10.1002/gps.3947 
Manni, R., Terzaghi, M., Ratti, P.-L., Repetto, A., Zangaglia, R., & Pacchetti, C. (2011). 
Hallucinations and REM sleep behaviour disorder in Parkinson’s disease: dream 
69 
 
imagery intrusions and other hypotheses. Consciousness and Cognition, 20(4), 
1021–1026. https://doi.org/10.1016/j.concog.2010.10.009 
Maria, B., Sophia, S., Michalis, M., Charalampos, L., Andreas, P., John, M. E., & 
Nikolaos, S. M. (2003). Sleep breathing disorders in patients with idiopathic 
Parkinson’s disease. Respiratory Medicine, 97(10), 1151–1157. 
Matsui, H., Udaka, F., Tamura, A., Oda, M., Kubori, T., Nishinaka, K., & Kameyama, M. 
(2006). Impaired visual acuity as a risk factor for visual hallucinations in 
Parkinson’s disease. Journal of Geriatric Psychiatry and Neurology, 19(1), 36–
40. https://doi.org/10.1177/0891988705284739 
Meppelink, A. M., de Jong, B. M., Renken, R., Leenders, K. L., Cornelissen, F. W., & 
van Laar, T. (2009). Impaired visual processing preceding image recognition in 
Parkinson’s disease patients with visual hallucinations. Brain: A Journal of 
Neurology, 132(Pt 11), 2980–2993. https://doi.org/10.1093/brain/awp223 
Meppelink, A. M., Koerts, J., Borg, M., Leenders, K. L., & van Laar, T. (2008). Visual 
object recognition and attention in Parkinson’s disease patients with visual 
hallucinations. Movement Disorders: Official Journal of the Movement Disorder 
Society, 23(13), 1906–1912. https://doi.org/10.1002/mds.22270 
Moeller, S., Yacoub, E., Olman, C. A., Auerbach, E., Strupp, J., Harel, N., & Uğurbil, K. 
(2010). Multiband multislice GE-EPI at 7 tesla, with 16-fold acceleration using 
partial parallel imaging with application to high spatial and temporal whole-brain 




Morrison, A. P., Wells, A., & Nothard, S. (2000). Cognitive factors in predisposition to 
auditory and visual hallucinations. The British Journal of Clinical Psychology, 39 ( 
Pt 1), 67–78. 
Muller, A. J., Shine, J. M., Halliday, G. M., & Lewis, S. J. G. (2014). Visual hallucinations 
in Parkinson’s disease: theoretical models. Movement Disorders: Official Journal 
of the Movement Disorder Society, 29(13), 1591–1598. 
https://doi.org/10.1002/mds.26004 
Onofrj, M., Taylor, J. P., Monaco, D., Franciotti, R., Anzellotti, F., Bonanni, L., … 
Thomas, A. (2013). Visual hallucinations in PD and Lewy body dementias: old 
and new hypotheses. Behavioural Neurology, 27(4), 479–493. 
https://doi.org/10.3233/BEN-129022 
Papapetropoulos, S., Katzen, H., Schrag, A., Singer, C., Scanlon, B. K., Nation, D., … 
Levin, B. (2008). A questionnaire-based (UM-PDHQ) study of hallucinations in 
Parkinson’s disease. BMC Neurology, 8, 21. https://doi.org/10.1186/1471-2377-
8-21 
Peraza, L. R., Kaiser, M., Firbank, M., Graziadio, S., Bonanni, L., Onofrj, M., … Taylor, 
J.-P. (2014). fMRI resting state networks and their association with cognitive 
fluctuations in dementia with Lewy bodies. NeuroImage. Clinical, 4, 558–565. 
https://doi.org/10.1016/j.nicl.2014.03.013 
Pieri, V., Diederich, N. J., Raman, R., & Goetz, C. G. (2000). Decreased color 
discrimination and contrast sensitivity in Parkinson’s disease. Journal of the 
Neurological Sciences, 172(1), 7–11. 
71 
 
Prell, T. (2018). Structural and Functional Brain Patterns of Non-Motor Syndromes in 
Parkinson’s Disease. Frontiers in Neurology, 9, 138. 
https://doi.org/10.3389/fneur.2018.00138 
Ramirez-Ruiz, B., Junque, C., Marti, M.-J., Valldeoriola, F., & Tolosa, E. (2007). 
Cognitive changes in Parkinson’s disease patients with visual hallucinations. 
Dementia and Geriatric Cognitive Disorders, 23(5), 281–288. 
https://doi.org/10.1159/000100850 
Rentrop, M., Rodewald, K., Roth, A., Simon, J., Walther, S., Fiedler, P., … Kaiser, S. 
(2010). Intra-individual variability in high-functioning patients with schizophrenia. 
Psychiatry Research, 178(1), 27–32. 
https://doi.org/10.1016/j.psychres.2010.04.009 
Seeley, W. W., Menon, V., Schatzberg, A. F., Keller, J., Glover, G. H., Kenna, H., … 
Greicius, M. D. (2007). Dissociable intrinsic connectivity networks for salience 
processing and executive control. The Journal of Neuroscience: The Official 
Journal of the Society for Neuroscience, 27(9), 2349–2356. 
https://doi.org/10.1523/JNEUROSCI.5587-06.2007 
Setsompop, K., Gagoski, B. A., Polimeni, J. R., Witzel, T., Wedeen, V. J., & Wald, L. L. 
(2012). Blipped-controlled aliasing in parallel imaging for simultaneous multislice 
echo planar imaging with reduced g-factor penalty. Magnetic Resonance in 
Medicine, 67(5), 1210–1224. https://doi.org/10.1002/mrm.23097 
Shin, Y. S., Kim, S. N., Shin, N. Y., Jung, W. H., Hur, J.-W., Byun, M. S., … Kwon, J. S. 
(2013). Increased intra-individual variability of cognitive processing in subjects at 
72 
 
risk mental state and schizophrenia patients. PloS One, 8(11), e78354. 
https://doi.org/10.1371/journal.pone.0078354 
Shine, J. M., Halliday, G. H., Carlos, M., Naismith, S. L., & Lewis, S. J. G. (2012). 
Investigating visual misperceptions in Parkinson’s disease: a novel behavioral 
paradigm. Movement Disorders: Official Journal of the Movement Disorder 
Society, 27(4), 500–505. https://doi.org/10.1002/mds.24900 
Shine, J. M., Halliday, G. M., Gilat, M., Matar, E., Bolitho, S. J., Carlos, M., … Lewis, S. 
J. G. (2014). The role of dysfunctional attentional control networks in visual 
misperceptions in Parkinson’s disease. Human Brain Mapping, 35(5), 2206–
2219. https://doi.org/10.1002/hbm.22321 
Shine, J. M., Keogh, R., O’Callaghan, C., Muller, A. J., Lewis, S. J. G., & Pearson, J. 
(2015). Imagine that: elevated sensory strength of mental imagery in individuals 
with Parkinson’s disease and visual hallucinations. Proceedings. Biological 
Sciences / The Royal Society, 282(1798), 20142047. 
https://doi.org/10.1098/rspb.2014.2047 
Shine, J. M., Muller, A. J., O’Callaghan, C., Hornberger, M., Halliday, G. M., & Lewis, S. 
J. (2015). Abnormal connectivity between the default mode and the visual system 
underlies the manifestation of visual hallucinations in Parkinson’s disease: a 
task-based fMRI study. NPJ Parkinson’s Disease, 1, 15003. 
https://doi.org/10.1038/npjparkd.2015.3 
Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E. (2010). 
Systematic review of levodopa dose equivalency reporting in Parkinson’s 
73 
 
disease. Movement Disorders: Official Journal of the Movement Disorder 
Society, 25(15), 2649–2653. https://doi.org/10.1002/mds.23429 
Tsuchiya, N., & Koch, C. (2005). Continuous flash suppression reduces negative 
afterimages. Nature Neuroscience, 8(8), 1096–1101. 
https://doi.org/10.1038/nn1500 
Wilke, M. (2012). An iterative jackknife approach for assessing reliability and power of 




The study was approved by the medical ethics committee of the University Medical 
Center Goettingen, Germany. All participants signed an informed consent form prior to 
the examination. 
Acknowledgements  
We thank Severin Heumüller for excellent computer and programming support and Dr. 
Holger Sennhenn-Reulen for helpful statistical discussions. 
Author Contributions  
(1) Research Project: A. Conception, B. Organization, C. Execution, Supervision; (2) 
Statistical Analysis: A. Design, B. Execution, C. Review and Critique; (3) Manuscript 
Preparation: A. Writing of the First Draft, B. Review and Critique. 
74 
 
K.M.: 1A, 1B, 1C, 2A, 2B, 3A, 3B; C.S.: 1A, 2A, 2B, 2C, 3B; K.W.: 2A, 2B, 2C, 3B; 
C.W.: 1B, 1C, 3B; C.T.: 1B, 1C, 3B; K.B.: 1B, 1C, 3B; M.B.: 1B, 1C, 3B; M.W.: 1A, 1C, 
2A, 2B, 2C, 3A, 3B. 
Funding 
This work was supported by the Herman and Lilly Schilling Foundation (MW), the DFG 
Center for Nanoscale Microscopy & Molecular Physiology of the Brain (CNMPB) and 





Misperceptions and intra-individual variability in Parkinson‘s disease:  
a behavioral and fMRI study 
Kristina Miloserdov et al. 
 
Supplementary Materials contains: 
Supplementary Methods and Materials (Apparatus and Stimuli)  
2 Supplementary Figures  




Supplementary Methods and Materials 
S.2.1.1. Apparatus and Stimuli 
Stimuli were presented on a 27 inch LCD monitor. The screen resolution was 1920 x 
1080 pixels. The monitor had a vertical refresh rate of 60 Hz. Participants were sitting in 
a dimly lit room. The eye-to-screen distance was 57 cm. Visual stimuli were presented 
with custom-written software using Matlab (Version R2011b, 32bit) and the 
Psychtoolbox for Microsoft Windows (Brainard, 1997). Responses were recorded with a 
USB button-box and behavioral responses were recorded in Matlab and stored together 
with the stimulus information on an x64-based PC. Target stimuli consisted of 
photographs of cars (http://vision.caltech.edu/archive.html), faces (Ekman & Friesen, 
1976) or their scrambled versions, presented in a pseudorandom manner. Each image 
subtended 480 pixels by 480 pixels and was presented in the center of the screen. Face 
stimuli were randomly drawn from different facial expressions. Scrambled images were 
generated using Matlab by dividing the images in 10 x 10 pixels blocks and randomizing 
their position (Figure 2.1A). Target images were presented monocular to the right eye 
by using red-blue goggles glasses and displaying the image solely by the blue gun 
(stereomode of the psychophysics toolbox (Carmel, Arcaro, Kastner, & Hasson, 2010)). 
In CFS trials, which were designed to suppress the images from visual awareness, high 
contrast and rapidly changing red-colored Mondrian patterns were flashed to the left eye 
at a frequency of 10 Hz (Tsuchiya & Koch, 2005). Thus, the right eye perceived the 
target image and the left eye perceived the Mondrian mask (Carmel et al., 2010) 
(Figure 2.1C). Mondrian patterns were drawn from a pool of 100 randomly generated 
patterns (http://martin-hebart.de/webpages/code/stimuli.html) (Stein, Hebart, & Sterzer, 
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2011). In the non-CFS condition, only the target image was presented to the right eye 
without the mask (Figure 2.1B).  
Supplementary Figures  
 
Supplementary Figure S2.1. Individual Perceptual Error and Intra-Individual Variability scores. (A) 
Individual PES values and boxplots illustrating the median in the center of the box, error bars the 95% 
confidence interval separated for HC (N = 25) in black, PD-nonVH (N = 16) in blue and PD-VH (N = 16) in 
red. (B) Individual CVRT and boxplots illustrating the median in the center of the box, error bars the 95% 
confidence interval separated values separated for HC (N = 25) in black, PD-nonVH (N = 16) in blue and 
PD-VH (N = 16) in red. 
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Supplementary Figure S2.2. Recognition time across trials. (A) Lines show mean and individual 
recognition times for the three intervals for face images of the non-CFS condition. Each bin corresponds 
to one third of correct trials. (B) Lines show mean and individual recognition times for the three time 
intervals, each interval consisting of one third of correct trials, of the non-CFS condition for car images. In 
(A) and (B), error bars show means and S.E.M. across subjects. HC: Healthy controls, PD-nonVH: 





Table S2.1. Demographic and neuropsychological characteristics of subjects that participated in 
the Resting state fMRI and image recognition task 
 HC 
(N = 19) 
PD 
(N = 16) 
 Mean (SD) Mean (SD) 
Age (years) 68.32 (6.30) 69.44 (8.52) 
Gender (female/male), n(%) 0 (0%) / 
19 (100%) 
3 (19%) /  
13 (81%) 
Education years 3.74 (2.06) 3.44 (1.62) 
MMSE 29.16 (0.90) 28.38 (1.31) 
Hoehn and Yahr stage - 2.06 (0.70) 
Disease duration - 7.67 (6.99) 
UPDRS III - 20.44 (11.91) 
LEDD, mg/day - 614.78 (397.31) 
UM-PDHQ - 3.63 (4.89) 
BDI 3.32 (2.83) 6.81 (4.64) 
Visual acuity (%) 97.89 (6.31) 92.50 (10.00) 
Mars Letters Contrast Sensitivity Test 1.73 (0.05) 1.72 (0.08) 
BDI, Beck’s, Depression Inventory; HC, healthy controls; LEDD, levodopa-equivalent daily dose; 
MMSE, Mini Mental State Examination; PD, Parkinson patients 
UM-PDHQ, University of Miami Parkinson's disease Hallucinations Questionnaire  
UPDRS, Unified Parkinson’s Disease Rating Scale;                          
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Supplementary Table S2.2. Results from ANOVA_1 in the non-CFS condition: Repeated Measures 
mixed ANOVA with the factors Category, Group and their interaction effects for Healthy controls 

















F (p) F (p) F (p) F (p) F (p) F (p) 
Category 2.03 
 (= 0.16) 
8.73                     
(= 0.0046)** 
 0.59  
(= 0.45) 
292.95            
(< 
0.00001)** 
Group 9.52  





















HC, Healthy controls (N  = 25); PD, Parkinson patients with and without visual hallucinations (N 
=  32) RT, Recognition times; CVRT, Mean individual variability coefficients (individual 
SD/individual mean) of recognition times  Between-subjects factor: Group: 2 Levels: HC, PD  
Within-subjects factors: Category: 2 levels: face, car   ** p < 0.005 Significant between and 
within main and interaction effects (Bonferroni correction p < 0.0025) # p < 0.05 Significant 








Supplementary Table S2.3. Results from the Repeated Measures mixed ANCOVA in the 
non-CFS condition: Repeated Measures mixed ANCOVA with the factors Category, 
Group, their interaction effects and the covariates disease duration and LEDD for 
Parkinson patients without visual hallucinations (PD-nonVH) and Parkinson patients with 

















 F (p) F (p) F (p) F (p) F (p) F (p) 
Category 1.78  
(= 0.19) 
1.03 
 (= 0.32) 
  1.21 
 (= 0.28) 
22.78                  
(= 
0.00005)** 
Group 1.96  
(= 0.17) 
0.94 
 (= 0.34) 
12.75 













 (= 0.70) 
0.18 




 (= 0.78) 
6.61 
 (= 0.02)* 
LEDD 2.73  
(= 0.11) 
0.84 
 (= 0.37) 
2.10 




 (= 0.67) 
1.06 








 (= 0.40) 
  0.01 
 (= 0.94) 
0.71 









 (= 0.54) 
   0.02 
 (= 0.89) 
2.38 






 (= 0.08) 
   0.72 
 (= 0.40) 
0.04 
 (= 0.84) 
PD-nonVH, Parkinson patients without visual hallucinations (N  = 16);                   
PD-VH, Parkinson patients with visual hallucinations (N =  16)    
RT, Recognition times; CVRT, Mean individual variability coefficients (individual SD/individual 
mean) of recognition times  
Between-subjects factor: Group: 2 Levels: PD-nonVH, PD-VH 
Within-subjects factors: Category: 2 levels: face, car    
Covariates: Disease duration, levodopa-equivalent daily dose (LEDD)                                                                                                                                                                   














Supplementary Table S2.4. Mean performance measures of the study groups in the CFS 
condition                                                                             
 HC 
(n = 25) 
PD-nonVH 
(n = 16) 
PD-VH 
(n = 16) 
Proportion Correct 
Recognition 
0.84 (0.04) 0.86 (0.03) 0.61 (0.08) 
Proportion Misses  0.14 (0.04) 0.09 (0.02) 0.31 (0.08) 
Proportion Erroneous Object 
Recognition in Scrambled 
Images 
0.08 (0.04) 0.08 (0.06) 0.21 (0.07) 
Perceptual Error Score 0.12 (0.03) 0.11 (0.04) 0.30 (0.05) 
RT faces  7.58 (0.35) 7.44 (0.45) 7.94 (0.35) 
RT cars 7.98 (0.33) 7.90 (0.40) 8.79 (0.34) 
CVRT faces  0.21 (0.01) 0.22 (0.02) 0.21 (0.03) 
CVRT cars 0.19 (0.02) 0.19 (0.02) 0.17 (0.03) 
Mean test values (S.E.M.) for each of the groups of the demographically matched sample. 25 Healthy 
controls (HC), 16 Parkinson patients without visual hallucinations (PD-nonVH), and 16 Parkinson patients 














Supplementary Table S2.5. Results from ANOVA_1 in the CFS condition: Repeated 
Measures mixed ANOVA with the factors Category, Group and their interaction effects in 


















































HC, Healthy controls (N  = 25);                   
PD, Parkinson patients with and without visual hallucinations (N =  32)    
RT, Recognition times; CVRT, Mean individual variability coefficients (individual SD/individual 
mean) of recognition times  
Between-subjects factor: Group: 2 Levels: HC, PD 
Within-subjects factors: Category: 2 levels: face, car                                                                                                                                                                     
* p < 0.025 Bonferroni corrected ** p < 0.005 Significant between and within main and 




Supplementary Table S2.6. Results from ANOVA_2 in the CFS condition: Repeated 

















































PD-nonVH, Parkinson patients without visual hallucinations (N  = 16);                   
PD-VH, Parkinson patients with visual hallucinations (N =  16)    
RT, Recognition times; CVRT, Mean individual variability coefficients (individual SD/individual 
mean) of recognition times  
Between-subjects factor: Group: 2 Levels: PD-nonVH, PD-VH 
Within-subjects factors: Category: 2 levels: face, car  
* p < 0.025 Bonferroni corrected ** p < 0.005 Significant between and within main and 





Supplementary Table S2.7. Results from the Repeated Measures mixed ANCOVA in the 
CFS condition. Repeated Measures mixed ANCOVA with the factors Category, Group, 
































































































PD-nonVH, Parkinson patients without visual hallucinations (N  = 16);                   
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PD-VH, Parkinson patients with visual hallucinations (N =  16)    
RT, Recognition times; CVRT, Mean individual variability coefficients (individual SD/individual 
mean) of recognition times  
Between-subjects factor: Group: 2 Levels: PD-nonVH, PD-VH 
Within-subjects factors: Category: 2 levels: face, car  
Covariates: Disease duration, levodopa-equivalent daily dose (LEDD)                                                    



















Supplementary Table S2.8. Partial correlations between within and between network 
functional connectivity estimates and logarithmic transformation of the Perceptual Error 
Score in Parkinson patients without visual hallucinations (PD-nonVH) (N = 6) and 
Parkinson patients with visual hallucinations (PD-VH) (N = 10)   
Log (Perceptual Error Score +1) 




 r (p) r (p) r (p) r (p) r (p) r (p) r (p) r (p) 






















































































































































































































































































Partial correlations corrected for Disease duration and LEDD of hallucinating and non-hallucinating 
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Behavioral variability is a marker of cognitive decline in different clinical and non-clinical 
groups such as healthy elderly (Bielak et al., 2010; Gorus et al., 2008; S. W. 
MacDonald, Nyberg, & Bäckman, 2006), Alzheimer’s disease (Gorus et al., 2008), 
neurological dysfunction related to lethal prognosis (Macdonald, Hultsch, & Dixon, 
2008) and Parkinson’s disease (Miloserdov et al., submitted). Mechanisms and sources 
of behavioral variability are still not fully understood and might be explained by neural 
processes (MacDonald et al., 2009).  High behavioral and neural variability is related to 
cognitive impairment and dementia (Bielak et al., 2010; Dinstein et al., 2015), in contrast 
to heart rate variability (HRV) which is related to higher cognitive functioning (Schaffer 
et al., 2014). To improve understanding of intra-individual variability we investigated age 
related changes in cognition in combination with psychophysical, cardiac and neural 
measurements. We tested whether healthy elderly show lower cognitive performance, 
higher behavioral variability, increased neural variability, increased theta power and 
reduced HRV. Moreover, we investigated whether lower cognitive functioning is related 
to behavioral, neural, cardiac variability and other possible marker of cognitive decline 
such as P1, P3 and changes in power of different frequency bands. Healthy elderly 
show more behavioral variability in response to cars, reduced P1 and P3 amplitude, 
higher change of theta power and lower cardiac variability compared to healthy young. 
Moreover, we could show that lower cognitive performance is related to higher 
behavioral variability and lower neural variability in healthy elderly. Behavioral and 




Behavioral variability can reflect optimal cognitive state while optimizing performance in 
a new complex task or suboptimal cognitive state by trying to hold the performance level 
in a familiar task (Li, Huxhold, & Schmiedek, 2004). The mechanisms of behavioral 
variability and their relation to neural variability are not fully understood. Neural 
variability might arise from different sources and pursue different aims. Adaptive 
variability serves to reach a goal using different strategies such as plasticity (to master 
large learning gains), diversity (explore different strategies to meet task complexity) and 
adaptability (to keep up optimal performance due to task challenges). While adaptive 
variability results from facing new challenges or improve achievements, maladaptive 
variability fluctuates in performance to master an already achieved performance level 
without additional challenges indicating a deficit in robustness (Li, Huxhold, & 
Schmiedek, 2004). Higher intra-individual variability in healthy elderly is related to 
reduced memory function (Papenberg et al., 2011). Intra-individual variability reflects 
age related cognitive decline (Bielak et al., 2010; Gorus et al., 2008; MacDonald et al., 
2006). Intra-individual variability in a complex task predicts mild cognitive impairment 
(MCI) and status of Alzheimers disease (Gorus et al., 2008) and is increased in 
hallucinating PD patients (Miloserdov et al., submitted). Moreover, intra-individual 
variability is an early marker of neurological dysfunction related to lethal prognosis 
(Macdonald et al., 2008). Mechanisms and sources of behavioral variability is still a 





3.1.1. Neural variability 
Neural processes underlying perception and cognition can be reflected by different 
measurements such as event-related potentials indicating early, perceptual and late, 
cognitive processes. Healthy elderly show changes in an early, perceptual component 
such as the P1 and late, cognitive component such as the P3. In healthy elderly P1 
amplitude is reduced and double peak occurs more often compared to healthy young 
adults (Stothart, Tales, Hedge, & Kazanina, 2014). In healthy elderly decreased P3 is 
related to working memory performance (Lubitz, Niedeggen, & Feser, 2017). P3 inter-
trial variability is related to more severe cognitive symptoms in schizophrenia (Kim et al., 
2018). Behavioral variability might be reflected by changes in temporal processing of 
information reflected in P3 reduction and variability. Another measurement of neural 
variability is variability quenching, the reduction of neural variability after stimulus 
presentation (Arazi, Censor, et al., 2017). In healthy young adults increased variability 
quenching, reduced neural variability, was related to better task performance (Arazi, 
Censor, et al., 2017). Older and slower performing adults showed less changes in brain 
variability (Garrett et al., 2013) indicating its potential as marker of cognitive changes 
during aging. Neural variability magnitudes are stable over time and test conditions in 
healthy young human volunteers (Arazi, Gonen-Yaacovi, et al., 2017) showing its 
reliability as a possible marker of cognitive changes.  
3.1.2. Time frequency subtypes and cognitive performance 
Different frequency bands are associated with different functions like gamma with visual 
perception, attention and memory (Jensen, Hougaard, Amin, Larsson, & Ashina, 2015), 
beta with motor function (He, Zhang, Chen, Xie, Gan, Yang, et al., 2017), alpha and 
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theta with cognition (Caviness et al., 2007). Changes in alpha and theta power might 
reflect changes in cognitive function. Individuals with MCI are characterized by reduced 
power in alpha and beta frequency and increased delta and theta power indicating the 
potential of these frequency bands as possible markers of cognitive decline (López et 
al., 2014). Theta oscillations are related to cognitive load, working memory, selective 
attention and cognitive integration (Givens, 1996; Vertes, 2005). Older adults show 
stronger theta power engaged in visual and audiovisual  detection task in frontal brain 
regions in contrast to younger volunteers showing stronger theta power in central 
regions (Yan et al., 2016). Theta power is related to better cognitive performance such 
as memory and attention in frontal brain regions of healthy elderly. Moreover, increased 
theta power correlates with reduced reaction time variability on the sustained attention 
task in frontal electrodes of healthy elderly (Finnigan & Robertson, 2011). Furthermore, 
healthy elderly show increased theta power compared to elderly with MCI (Cummins, 
Broughton, & Finnigan, 2008) and PD patients with MCI (He, Zhang, Chen, Xie, Gan, 
Wang, et al., 2017). In addition, transition from MCI to Alzheimer’s disease is 
characterized by lower theta power in temporal, occipital, parietal and frontal electrodes 
indicating increased theta power as a marker of cognitive functioning (Mazaheri et al., 
2018). However, resting state EEG shows global increase in theta power in AD and 
increase in theta power is related to worse cognitive performance in MCI and PD 
indicating higher levels of theta power as an possible early marker of cognitive decline 
(He, Zhang, Chen, Xie, Gan, Wang, et al., 2017; Musaeus et al., 2018). At first glance 
cognitive changes, differences in spectral frequency power and neural variability might 
provide explanations about behavioral variability. However, other regulatory systems, 
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such as the parasympathetic nervous system might play a role in changes of behavioral 
variability. 
3.1.3. Heart rate variability 
The parasympathetic nervous system is important for self-regulation which is related to 
cognition, emotion and health. HRV is the difference in time intervals between 
heartbeats which is part of the autonomous regulatory systems that is necessary to 
master challenges and optimize performance (Shaffer et al., 2014). Improvement of 
self-regulation involving HRV can be achieved by the heart and brain network. The 
heart receives input from the parasympathetic nervous system (Chapleau & Sabharwal, 
2011). Different theories discuss possible mechanisms of this connection and the role of 
HRV in this network. Porge’s polyvalgal theory assumes that the vagal nerve which can 
slow down the heart rate, contain specialized subsystems for regulation of adaptive 
responses. The older unmyelinated nerves regulate freezing behavioral responses and 
the newer myelinated nerves originating from the nucleus ambiguus,  are important for  
self-regulatory ability by inhibiting sympathetic outflow to the heart (Shaffer et al., 2014). 
Increased vagal tone is related to better social functioning (Porges, 2007). The 
neurovisceral integration model assumes a connection between the heart and the 
prefrontal cortex through the central autonomic network and the vagus (Thayer, 
Hansen, Saus-Rose, & Johnsen, 2009). Higher vagal tone reflects better executive 
cognitive performance, emotional and health regulation (Thayer, Hansen, Saus-Rose, & 
Johnsen, 2009). HRV is regulated by connections between amydgala and medial 
prefrontal cortex. HRV is linked to executive functions, reflecting the functional capacity 
of the brain to support working memory and self-regulations. It is hypothesized that to 
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inhibit unpleasant memories the central autonomic network could decrease prefrontal 
activation, increase heart rate and reduce HRV (Shaffer et al., 2014). McCraty and 
Childre’s Psychophysiological coherence model proposes that time intervals between 
the heart beats encode information which helps synchronize multiple systems, 
emphasising the afferent pathways carrying input from the heart to the brain (Shaffer et 
al., 2014). HRV decreases with age (for review see (Shaffer et al., 2014). Cognitive 
functioning is related to increased rest HRV (Thayer et al., 2009). HRV might not only 
play a role for cognitive changes related to aging (Shaffer et al., 2014) as in healthy 
young volunteers HRV varies as function of demands in sustained attention (Luque-
Casado, Perales, Cárdenas, & Sanabria, 2016). Moreover, regulation of the outonomic 
outflow of the heart might be affected by neurodegenerative changes in Parkinson and 
dementia. HRV as a marker of parasympathetic activity and it is related to increased 
risk developing PD but not other measures of cardiac autonomic function including 
frequency-domain measurements (Alonso, Huang, Mosley, Heiss, & Chen, 2015). HRV 
is an index of self-regulatory control, greater resting HRV is related to better 
performance of executive functions (Shaffer et al., 2014). High behavioral and neural 
variability is related to cognitive impairment and dementia (Bielak et al., 2010; Dinstein, 
Heeger, & Behrmann, 2015) and HRV to improved cognitive functioning (Shaffer et al., 
2014). 
Intra-individual variability and its neural correlates might provide a marker for different 
profiles of Parkinson symptoms. Improvements in understanding mechanisms and 
sources of intra-individual variability might promote differential diagnosis and maybe 
even more individualized treatment. To improve understanding of intra-individual 
variability we investigated age related changes in cognition in combination with 
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psychophysical, cardiac and neural measurements. This might provide new insights into 
behavioral, neural and cardiac variability and its relation to age related cognitive 
changes. We expect that healthy elderly show lower cognitive performance, higher 
behavioral variability, increased neural variability, increased theta power and reduced 
HRV. Moreover, we expect that lower cognitive functioning is related to higher theta 
power, higher behavioral and neural variability and lower HRV.  
3.2. Materials and Methods 
3.2.1. Participants 
Forty-eight healthy volunteers (26 Healthy Elderly) and (22 Healthy Young) without 
history of neurological or psychiatric diseases were recruited. ECG of 24 older 
participants and 20 younger participants were used (in two subjects ECG was not 
recorded and in two subjects data quality was not sufficient for further analyses). Two 
Healthy Elderly participants did not follow the instructions and were excluded from 
further analyses. All participants signed an informed consent form prior to the 
examination. Exclusion criteria were moderate to severe general cognitive 
impairment/dementia (Mini Mental State Examination (MMSE) score < 26) (Folstein, 
Folstein, & McHugh, 1975), visual acuity below 80% (Poster Radler 2010). The Healthy 
Young and Healthy Elderly did not differ on demographic variables such as years of 
education (t(46) = 1.27, p = 0.21, gender (X2= 0.95, p = 0.76) and handedness (X2= 
0.34, p = 0.84) assessed by Edinburgh Handedness Inventory (Table 3.1). Given that 
depression is less prevalent in older adults compared to younger adults we measured 
depressive symptoms using Beck Depression Inventory (Beck, Ward, Mendelson, 
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Mock, & Erbaugh, 1961). However, the lower BDI scores in Healthy Elderly were not 




Table 3.1. Demographic and cognitive characteristics of Healthy Young and Healthy Elderly. 
 Young  
(N = 22) 
Elderly 
(N = 24) 
P- value 




24.77 (3.90) 63.25 (7.98) < 0.00001* 
Gender (female/male)
d
,   n (%) 




17.27 (2.75) 15.92 (4.33) = 0.21 
MMSE
c













28.05 (7.52) 27.18 (6.32) 
= 0.69 
Stroop Test RT contgruent (ms)
a
 
987,67 (165.22) 1361.756 (257.84) 
< 0.001** 




1059.72 (200.49) 1584.93 (415.61) 
< 0.001** 
Stroop Test CVRT congruent
c
 
31.83 (12.21) 38.46 (13.44) 
= 0.06 
Stroop Test CVRT noncongruent
c
 
























 5.10 (3.48) 3.30 (3.66) = 0.10 




1.81 (0.04) 1.79 (0.04) = 0.35 




18 / 3 / 1                 
(82% / 14% / 4%) 
21 / 2 / 1                         





t-test with unequal variances 
c
Mann-Whitney U test; 
d
Chi-square -test;  
MMSE, Mini Mental State Examination; BDI, Beck’s, Depression Inventory; 
RT, Recognition times, CVRT, Coefficient of Recognition time variability 




3.2.2. Neuropsychological Testing 
Contrast sensitivity was evaluated with the Mars Letters Test (Mars Perceptrix 
Corporation, Chappaqua, NY, USA). Participants filled in a self-report depression scale 
(Beck’s Depression Inventory, BDI) (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961b). 
Different domains of cognitive functioning are reduced in healthy elderly (Hedden & 
Gabrieli, 2004). To asses these cognitive differences we used the Trail Making Test 
(TMT) (Reitan, & Wolfson, 1993), Verbal Fluency test (Troyer, Moscovitch, & Winocur, 
1997) and the Stroop test (Stroop, 1935). To test motor differences in rhythm formation 
we used the Finger Tapping Test (Arias, Robles-García, Espinosa, Corral, & Cudeiro, 
2012) where participants were instructed to press a button with the index finger of their 
dominant hand at a comfortable rate (speed of their choice), and to try to maintain a 
constant interval between each of their button presses. Subjects performed 3 sets of 53 
button presses. Moreover, to test age differences in simple reaction time variability we 
designed a Simple Reaction Time test in which participants were asked to press a 
button with the index finger of their dominant hand as soon as they saw a cue on the 
screen. The task consisted of 50 trials, each separated by a random interval ranging 
from 0.5 to 1.5 seconds. 
3.2.3. Image Recognition Task 
Participants were placed in a dark room and asked to lay their heads in a chin-rest to 
limit head movements. The chin-rest was placed at a distance of 57 cm from the 
computer screen. Participants had to identify different images presented at a high and 
low contrast level while their brain activity was recorded using EEG. The task was 
designed based on the results of our previous study  which revealed higher recognition 
102 
 
time variability in hallucinating PD patients compared to non-hallucinating PD patient 
where the contrast of the stimulus was stepped up continuously (Miloserdov et al., 
submitted). Using high and low contrast level we were aiming to investigate whether 
high or low contrast stimuli contribute more to recognition time variability.  
3.2.3.1. Stimuli 
The stimuli were presented with a custom script using Matlab version R2011b and the 
Psychtoolbox (Brainard, 1997) on a 27 inch LCD monitor with a screen resolution of 
1920 x 1080 pixels and a vertical refresh rate of 60 Hz. The stimuli were photographs of 
three different objects: cars, faces and scrambled images (Figure 3.1A). Images had a 
size of 480 x 480 pixels (15° of visual angle), and were presented at the center of the 
screen. The photographs of the cars were obtained from the Caltech image archive 
(http://vision.caltech.edu/archive.html), and the photographs of faces, from the Paul 
Ekman Group picture bank (Ekman & Friesen, 1976). We presented 10 different faces 
and 10 different cars. It is important to mention that all the faces presented had a 
neutral expression. Scrambled images were created dividing the images of faces and 
cars into 10×10 pixels blocks and randomizing their position using Matlab (Figure 
3.1A). The three types of stimuli were shown at 100% and 10% contrast, giving us a 
total of six different conditions (i.e. cars at 100% and 10% contrast, faces at 100% and 




Figure 3.1. Task design and trial structure. A) Example images of face, car and scrambled images 





3.2.3.2. Trial Sturcture 
Each trial (Figure 3.1B) started with prefixation of 1 second, during which a black 
screen was shown. Prefixation was followed by a white fixation cross on a black 
background presented for 2 seconds in the center of the screen. After the fixation 
period, a jitter between 1.7 to 2.3 seconds preceded the presentation of the stimulus, 
which was presented for 2 seconds. The participants were instructed to give their 
answer as soon as possible. They had to categorize the object on the screen (either 
car, face or scrambled image, at 10% or 100% contrast), giving their answers with a 
button-box using their index, middle and ring fingers (participants were told which button 
corresponded to which object before starting the task). To avoid biases in the reaction 
times of a particular stimulus that could be caused by differences in the speed of a 
particular finger (Wilimzig, Ragert, & Dinse, 2012), we assigned one of three different 
possible button orders to each participant. Regardless of the time it took participants to 
respond, the stimulus remained on the screen for 2 seconds. After their response, they 
were prompted to confirm their answer. If the participants did not reply within the 2 
seconds of the presentation of the stimulus, they were asked to guess which object was 
presented on the screen. After their response, the next prefixation period would start. 
The task was structured in a block manner. The participants had to complete a total of 8 
blocks. Each block consisted of a total of 60 trials. In every block, each condition was 
presented ten times in a pseudo-randomized manner, giving us a total of 80 trials per 





3.2.4. EEG Recording and Preprocessing  
EEG data was recorded at a sampling rate of 1000 Hz using a 64-channel Brain 
Products system elastic cap. The cap includes a reference electrode located at FCz. 
The FieldTrip toolbox for Matlab (Oostenveld, Fries, Maris, & Schoffelen, 2011) was 
used for processing the data. Continuous EEG data was segmented into 3000 ms long 
epochs (1500 ms prestimulus to 1500 ms poststimulus). Data was filtered offline using a 
0.1-220 band-pass filter (butterworth, hamming window) and a 50 Hz notch filter. Jumps 
and clips were interpolated and trials containing muscle artifacts were rejected. Blink 
artifacts were corrected using Independent Component Analysis (ICA). Data was re-
referenced to the common average. Given that evidence suggests that face processing 
is associated with cognitive performance (Feuerriegel, Churches, Hofmann, & Keage, 
2015; Saavedra, Olivares, & Iglesias, 2012) we focused our analyses on the electrodes 
near the anatomical regions associated with face processing (TP10, TP8, PO8, P8, 
TP9, TP7, P7, PO7 electrodes, which include the middle/posterior fusiform gyrus and 
the posterior superior temporal sulcus (Jonas et al., 2016). All analyses were performed 
separately for each of the stimuli (cars, faces and scrambled images), as well as each 
contrast level (100% and 10%).  
3.2.4.1. Time domain analysis 
For the time domain analysis, data was filtered using a low pass filter of 40 Hz 





3.2.4.2. Event Related Potentials 
To evaluate the event related potentials (ERP) a baseline of - 200 to 0 ms before 
stimulus presentation was used and the mean amplitude for the ERP of interest, P1 and 
P3, was calculated. Given that early visual processes are expected to be reflected in V1 
we  calculated the mean amplitude of the P1 component for each group over the O1 
and O2 channels using a time window of 70 to 130 ms after stimulus presentation 
(Wykowska & Schubö, 2012). Given that parietal P3 is sensitive for perceptual 
difference between stimulus types (Harper, Malone, & Iacono, 2017) we derived the 
signal of P3, P4 electrodes for calculation of the area of the amplitude of P3 using a 
time window of 400 to 620ms after stimulus presentation (Salti, Bar-Haim, & Lamy, 
2012) which is sensitive to changes in amplitude in perceptual priming of different 
stimuli such as faces and objects (Guillaume et al., 2009).  
3.2.4.3. Time-frequency analysis 
To investigate whether differences in different frequency bands indicate age related 
cognitive changes as was shown in PD patients and patients with MCI (Cummins et al., 
2008; He, Zhang, Chen, Xie, Gan, Wang, et al., 2017; Latreille et al., 2016), we 
calculated the mean power of different frequency bands such as alpha, beta, gamma 
and theta. For the time frequency analysis, each 3000 ms epoch was transformed to the 
time-frequency domain using a fast Fourier Transform with the application of a Hanning 
taper and a sliding window of frequency-dependent size (5 cycles of the frequency of 
interest per window). Each of the time windows was shifted by 10ms along the time 
domain. The mean power across trials for each frequency band (Theta: 4-7 Hz, Alpha: 
8-13 Hz, Beta: 14-20 Hz and Low-Gamma: 25-40Hz) was calculated as percentage 
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change units with respect to a baseline of -500 to -200ms (Powerprestim) before stimulus 
presentation. A single value of mean power change was obtained for each subject for 
the time window of 100 to 400ms after the stimulus presentation (Powerpoststim) with 
respect to the baseline (Power change = (Powerpoststim - Powerprestim) /  Powerprestim 
*100). This value was used for analyzing differences between the groups and the 
correlation of band mean power with measures of cognitive and perceptual 
performance.  
3.2.4.4. Variability quenching 
To test age-related changes in neural variability we computed trial-by-trial variability 
separately for each subject computed for each time point in the epochs (-500 to 500 ms) 
for the electrodes of interest.  Trials were analyzed for each of the conditions separately 
(cars at 100% or 10% contrast, faces at 100% or 10% contrast or scrambled images at 
100% or 10% contrast) and also grouped by contrast level. To calculate the variability 
quenching elicited by the presentation of the stimulus, two time windows were defined: 
the prestimulus time window (-200 to 0 ms) and the post-stimulus time window (100 to 
400 ms). Then, absolute trial-by-trial variability for the pre and poststimulus intervals 
was computed as the mean variance of all the time points in the prestimulus (Varpre) and 
poststimulus (Varpos) time windows. Relative trial-by-trial variability (i.e. quenching level) 
was computed as the percentage of the difference between the variance in the 
poststimulus interval and the prestimulus interval based on the calculations performed 
by (Arazi, Gonen-Yaacovi, et al., 2017) as shown in the following equation:  







3.2.6. Heart Rate Variability 
One electrode of the electrodes of the 64 chanel system was placed on the back, 
thoracal paravertebral. The data were collected with a sampling rate of 1000 Hz 
resulting in a temporal resolution of 1 ms for the time interval between consecutive R-
peaks of the heart signal (RR interval). ECG was recorded during the 8 blocks of the 
task and a 2 minutes Resting state with eyes closed before and after the task. R peak 
detection was performed using Brain Vision Analyzer (Brain Products GmbH, Gilching, 
Germany). To exclude artifacts RR intervals which differed more than 25% from 
previous and subsequent RR intervals (Malik, Cripps, Farrell, & Camm, 1989). Excluded 
RR intervals were replaced by conventional spline interpolation providing the same data 
length or same number of beats (Luque-Casado et al., 2016). Further analyses were 
conducted using Kubios with smoothness prior mentod with a Labda value of 500 to 
remove disturbing low frequency baseline trend components (Tarvainen, Niskanen, 
Lipponen, Ranta-Aho, & Karjalainen, 2014).  
3.2.7. Statistical Analyses 
3.2.7.1. Neuropsychological tests 
General differences in demographic and neuropsychological factors such as age and 
depressive symptoms scored with BDI were tested using t-tests. Mann-Whitney test 
was used when the assumption of normality was violated for testing group differences in 
years of education, MMSE, Trail Making Test part A, part B, Verbal Fluency, Stroop 
Test, Simple Rection time Test, Finger Tapping Test, Mars Letters Contrast Sensitivity 
Test. To test group differences in gender and handedness we used Chi Square Test. 
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3.2.7.2. Task and Neural measures 
To test whether Healthy Elderly would show worse performance, higher behavioral 
variability (Bielak et al., 2010; Gorus et al., 2008; MacDonald et al., 2006), differences in 
neural variability and power of frequency bands, especially in theta power (Cozac et al., 
2016) we performed a mixed repeated measures ANOVA with the whithin subject 
factors, contrast (two levels: 10% and 100%), category (three levels: face, car, 
scrambled) and group as a between subject factor with two levels, Healthy Young and 
Healthy Elderly. Using the above described ANOVA we tested group differences of the 
performance measures such as Proportion Correct Recognition (proportion correct 
categorization of faces, cars and scramble images), Perceptual Error Score (PES) 
consisting of category confusions and misses, mean recognition time, coefficient of 
recognition time variability (individual recongition time mean divided by individual 
standart deviation of recogniton time) (CVRT). We used the reteated measures ANOVA 
to investigated differences for the neural correlates of task performance such as P1, P3 
amplitude, change in frequency power of alpha, beta, gamma and theta bands and 
variability quenching for the time windows, 100-400 ms, 100-200 ms, 200-300 ms and 
300-400 ms after stimulus presentation. Greenhouse- Geisser corrected statistics (F 
and p values) were reported. Post hoc test were t-tests and were Bonferroni corrected 
by dividing the signficance level of 0.05 by the amount of comparisons (CVRT for the 
three different categories p < 0.016; ERP and frequency power for the six comparisons 
of the three categories and two contrasts p < 0.0083; p <; variability quenching for the 
eight comparisons with four comparisons (three categories and one contrast pooled 




3.2.7.3. Heart Rate Variability  
To investigate age differerences in cardiac variability we tested differences in HRV 
between Healthy Young and Healthy Elderly as well as in RMSSD (root mean square of 
successive differences), High frequency (HF) (0.15 to 0.40 Hz), Low frequenchy (LF) 
(0.04 to 0.15 Hz) and LF to HF ratio, in the Resting state before the task, during task 
performance and Resting state after the task using t-tests.  Bonferroni correction was 
applied for multiple comparisons of different heart rate variability measures, resulting in 
a significance threshold of p < 0.0042. 
3.2.7.4. Correlations 
To test whether intra-individual variability is related to cognitive changes, neural 
variability, change in power of freuquency bands and cardiac variability we performed 
Spearman’s rho correlations separate for each group between task measurements such 
as intra-individual variability and perceptual error score, cognitive measurements such 
as Trail Making Test and Stroop Test, neural measurements such as variability 
quenching, change in frequency power, P1 and P3 amplite, HRV measurements such 
as RMSSD, HF power, LF power and LF to HF ratio. Outlier were defined as 2 SD 
below or above the mean within the group were excluded and spearman’s rank 




3.3. Results   
To test whether there are general cognitive differences in Healthy Young and Healthy 
Elderly we tested differences on cognitve tests such as the Trail Making Test, Stroop 
test expecting Healthy Elderly to need more time  to solve the tests. Healthy Young 
needed less time to solve the Trail Making Test A and B (Trail Making Test A: U = 238, 
p = 0.0003, Trail Making Test B: U = 160, p = 0.02, Stroop test congurent trials: t(43) = -
5.77, p < 0.001; Stroop test incongruent trials: U(43) = 48, p < 0.001) indicating lower 
cognitive function in Healthy Elderly (Table 3.1). 
3.3.2. Correct image recognition in the main task  
To test whether our task is sensitive in indicating minor cognitive changes we compared 
error proportions in Healthy Young and Healthy Elderly expecting Healthy Elderly to 
make more mistakes. Young and elderly subjects showed comparable proportion of 
recognition errors. Both groups made more errors in the lower contrast condition for 




Table 3.2. Repeated measures mixed ANOVA with the factors contrast, category and group of 






















3.65 (= 0.04)*  1.07 (= 0.35) 0.78 (= 0.46) 
Group 1.92 (= 0.17) 1.19 (= 0.28) 5.78 ( = 0.02)* 3.04 ( = 0.09) 2.64 (= 0.11) 
Contrast x 
Group 
0.07 ( = 0.79) 3.94 (= 0.054) 1.04 (= 0.13) 8.12 (= 0.007)* 0.27 ( = 0.60) 
Category x 
Group 









3.65 (= 0.04)*  0.59 (= 0.52) 1.06 (= 0.36) 
RT, Recognition times; CVRT, Mean individual variability coefficients (individual SD/individual mean) of 
recognition times                                                                                                                                                                
Between-subjects factor: Group: 2 Levels: Young, Elderly  Within-subjects factors: Category: 3 levels: 
face, car, Contrast: 2 levels: contrast 10%, contrast 100%                                                                                                                                                                 




Figure 3.2. Proportion correct image recognition. Mean proportion of correct recognition of A) faces, 
B) cars and C) scrambled images. Means across subjects in each group are shown. Error bars denote 
S.E.M. across subjects. ** denotes a significant difference for low and high contrast condition, p < 0.005 
(black star: 10% Contrast vs. 100% Contrast as assessed by the ANOVA). 
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Figure 3.3 shows more missed responses, within the 2 seconds of stimulus 
presentation in the low contrast condition in Healthy Elderly and Healthy Young 
volunteers (Table 3.2).  
 
Figure 3.3. Proportion misses. Mean proportion of correct recognition of A) faces, B) cars and C) 
scrambled images. Means across subjects in each group are shown. Error bars denote S.E.M. across 
subjects. ** denotes a significant difference, p < 0.005 (black star: 10% Contrast vs. 100% Contrast as 




3.3.3. Perceptual Error Score (PES)  
Assuming that a combined sum score (Shine et al., 2012) of different image recognition 
errors is more robust as was shown in clinical studies than the separate ones, we 
computed a sum error score (PES) of category confusion, misses and false real image 
detection in scrambled images, similar to Shine et al. (Shine et al., 2012). Both, Healthy 
Young and Elderly show an increase in perceptual errors for the low contrast condition 
(Figure 3.4A). Healthy Elderly showed an increase in perceptual errors compared to 
Healthy Young (Healthy Young: 0.35, Healthy Elderly: 0.43, F(1,44) = 5.78, p = 0.02 




Figure 3.4. Perceptual Error Score. Mean proportion Perceptual Error Score, separated by subject 
group, Healthy Young (N = 22) and Healthy Elderly (N = 24).  In all panels, means across subjects in 
each group are shown. Error bars denote S.E.M. across subjects for A) differences between groups in 
low and high contrast and B) mean difference between groups independent of contrast level. ** denotes a 
significant difference, p < 0.005 (black star as assessed by the ANOVA) # denotes a difference p < 0.05 




3.3.4. Mean Recognition times 
To investigate whether age has effects on response speed we compared both groups 
expecting Healthy Elderly to be slower in responding (Deary & Der, 2005). In contrast to 
our expectation Healthy Elderly volunteers responded faster in categorization of the 




Figure 3.5.  Mean Recognition times. Mean Recognition time of A) faces, B) cars and C) 
scrambled images, separated by subject group, Healthy Young (N = 22) and Healthy Elderly 
(N = 24).  In all  panels, means across subjects in each group are shown. Error bars 
denote S.E.M. across subjects. ** denotes a significant difference between low and high 
Contrast condition, p < 0.005 (black star as assessed by the ANOVA).   
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Figure 3.6 illustrates that in Healthy Young volunteers higher recognition times are 
related to lower proportion of correct categorization for facial and scrambled images 
showing that those Healthy Young volunteers who made more mistakes needed more 
time which does not provide an explanation for longer RT in Healthy Young.  
 
Figure 3.6. Correlation of Recognition time and Proportion correct performance. Correlation of the 
low contrast condition for proportion correct displayed on the x-axis and recognition times on the y-axis for 
A) facial images B)  car images C) scrambled images. Green dots show the individual values of Healthy 
Young volunteers (N = 22) and grey dots the individual values of Healthy Elderly volunteers (N =  24). 
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3.3.5. Intra-individual variability of recognition times 
The previous study of our group showed that CVRT was increased in hallucinating PD 
patients. Investigating possible mechanisms of CVRT we could show that both, Young 
and Elderly show increased CVRT for the high contrast condition of car and scrambled 
stimuli (Figure 3.7 B and C, Table 3.2). In addition, the “Group x Object” interaction 
indicates differences between the Healthy Young and Healthy Elderly in CVRT for 
certain stimuli (F(1,44) = 3.88, p = 0.03). Elderly volunteers show increased variability 
for cars compared to Healthy Young subjects (Young: 0.16, Elderly: 0.20, t(44) = -2.94, 




Figure 3.7. Differences in Coefficient of recognition times variability. Average of 
individual variabil ity in RT (CVRT = individual standard deviation of  RT divided by the 
individual RT mean), separated by stimulus type, A) face, B) car, C) scrambled image , 
contrast level 10%, 100% and by subject group, Healthy Young (N = 22) in green and 
Healthy Elderly (N = 24) in gray. In D) averages of  CVRT separated by stimulus type and 
subject group are shown. In al l  panels, means across subjects in each group are shown. 
Error bars denote S.E.M. across subjects.  * denotes a significant difference between high 
and low contrast condition, p < 0.05 (black star as assessed by post-hoc tests).  
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3.3.6. Correlation of intra-individual variability of recognition times (CVRT) and 
cognitive measures 
To investigate factors that might explain increase in behavioral intra-individual variability 
of recognition times in Healthy Young and Healthy Elderly we performed Spearman’s 
rank correlations between CVRT and cognitive measures such as the time of the Trail 
Making Test and Verbal Fluency Test. Figure 3.8, 3.9 illustrate that only in Healthy 
Elderly increased CVRT for low contrast faces was related to longer times to complete 
Trail Making Test part A (rs = 0.49, p = 0.02) and average of all low contrast stimuli to 
longer times to complete the Trail Making Test part A and part B (p ≤ 0.03), indicating 
that reduced executive functioning is related to increased behavioral variability in 
Healthy Elderly volunteers. These correlations remain significant after removing six 




Figure 3.8. Association of coefficient of recognition time variability with Trail Making Test part A. 
Correlation between CVRT for A) faces B) cars and C) scrambled images Contrast 10% displayed on the 
x-axis and time solving Trail Making Test part A on the y-axis, left whole sample and right without outlier 
(± 2SD from the average within the group). Green dots show the individual values of Healthy Young 
volunteers (N = 22, without outliers: N = 19) and grey dots the individual values of Healthy Elderly 




Figure 3.9. Association of coefficient of recognition time variability with Trail Making Test part A 
and B. Correlation between CVRT average of all category types of Contrast 10% displayed on the x-axis 
and time solving Trail Making Test A) part A and B) part B on the y-axis, left whole sample and right 
without outlier (± 2SD from the average within the group). Green dots show the individual values of 
Healthy Young volunteers (N = 22, without outliers: N = 19) and grey dots the individual values of Healthy 






3.3.7. Event-related Potentials 
To investigate differences in neural correlates of perceptual and cognitive processes we 
measured differences in P1 and P3 amplitude between Healthy Elderly and Healthy  
Young expecting lower amplitudes in Healthy Elderly (Hsieh & Lin, 2017). The expected 
lower P1 Amplitude in Healthy Elderly is supported by the main effect of Group (F(1,44) 
= 5.57, p = 0.023). Figure 3.10 illustrates the lower P1 Amplitude for low contrast 
condition and Figure 3.11 the lower P3 Amplitude for high contrast condition in Healthy 
Elderly compared to Healthy Young (Table 3.3). This is supported by the interaction 
effect of “Contrast x Category x Group” of P1 (F(1,44) = 5.22, p = 0.01) and the 
interaction effect of “Contrast x Group” of P3 (F(1,44) = 18.59, p < 0.0001). Post-hoc 
tests, Bonferroni corrected for multiple comparisons of the different conditions 
(significance threshold p < 0.0083) showed lower P1 Amplitude for cars and scrambled 
images and a tendency for facial images in the low contrast condition and a tendency 
for cars in the high contrast condition in Healthy Elderly volunteers (Contrast 10%: 
faces: t(44) = 2.36, p = 0.02; cars: t(44) = 3.13, p = 0.003; scrambled: t(44) = 3.01, p = 
0.004; Contrast 100%: faces: t(44) = 1.78, p = 0.08; cars: t(44) = 2.74, p = 0.009; 
scrambled: t(44) = 0.03, p = 0.98) and lower P3 amplitude for cars and a tendency for 
faces and scrambled images in the high contrast condition in Healthy Elderly compared 
to Healthy Young (Contrast 10%: faces: t(44) = 0.71, p = 0.48; cars: t(44) = 0.90, p = 
0.37; scrambled: t(44) = 1.02, p = 0.32; Contrast 100%: faces: t(44) = 2.41, p = 0.02; 




Table 3.3. Event Related Potentials: Repeated measures mixed ANOVA with the factors contrast, 
category and group of Healthy Young (N = 22) and Healthy Elderly (N = 24)  
 P1 Amplitude P3 Amplitude 
 F (p) F (p) 
Contrast 4.19 (= 0.047)* 81.69(< 0.0001)** 
Category 19.87 (< 0.0001)** 3.89 (= 0.03)* 
Group 5.57 (= 0.023)* 3.59 (= 0.07) 
Contrast x Group 1.16 (= 0.29) 18.59 (< 0.0001)** 
Category x Group 5.37 (= 0.008)* 1.41 (= 0.25) 
Contrast x Category x Group 5.22 (= 0.01)* 1.85 (= 0.17) 
Contrast x Category 16.36 (< 0.0001)** 1.45 (= 0.24) 
Between-subjects factor: Group: 2 Levels: Young, Elderly                                                                           
Within-subjects factors: Category: 3 levels: face, car, Contrast: 2 levels: contrast 10%, contrast 100%                                                                                                                                                                 




Figure 3.10: Differences in P1 Amplitude.  P1 Amplitude derived f rom the electrodes O1, 
O2, separated by stimulus type, A) face, B)  car, C) scrambled image and by subject 
group, Healthy Young (N = 22) in green and Healthy Elderly (N = 24) in gray. On the left in 
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all panels, means of  the P1 amplitude across subjects in each group are shown. Error bars 
denote S.E.M. across subjects. In the center P1 amplitude and on the r ight the spatial 
distribution of  P1 Amplitude for the high contrast condition is shown. ** denotes a 
significant difference between Healthy Young and Healthy Elderly, p < 0.005. * denotes a 
significant difference between Healthy Young and Healthy Elderly, p < 0.008 (black star as 
assessed by ANOVA and post -hoc t-tests).  # denotes signif icant difference without 
Bonferroni correction, p < 0.05 (assessed by ANOVA and post -hoc t-tests). On the r ight  
mean EEG activ ity is shown in green for Healthy Young (N = 22) and in grey for Healthy 





Figure 3.11: Differences in P3 Amplitude.  P3 Amplitude derived f rom the electrodes P3, 
P4, separated by stimulus type, A) face, B) car, C) scrambled image and by subject group, 
Healthy Young (N = 22) in green and Healthy Elderly (N = 24) in gray. On the left in al l 
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panels, means of  the P3 amplitude across subjects in each group are shown. Error bars 
denote S.E.M. across subjects. In the center P3 amplitude and on the r ight the spatial 
distribution of  P3 Amplitude for the high contrast condition is shown. ** denotes a 
significant difference between Healthy Young and Healthy Elderly, p < 0.005. * denotes a 
significant difference between Healthy Young and Healthy Elderly, p < 0.008 (black star as 
assessed by ANOVA and post -hoc t-tests).  # denotes signif icant difference without 
Bonferroni correction, p < 0.05 (assessed by ANOVA and post -hoc t-tests). On the r ight  
mean EEG activ ity is shown in green for Healthy Young (N = 22) and in grey for Healthy 
Elderly (N = 24). 
 
3.3.8. Correlation of Event related Potentials and cognitive measurements 
To investigate whether P1 and P3 amplitudes would show age related cognitive 
changes we correlated P1 and P3 amplitude with cognitive and motor measures 
expecting lower amplitude being related to lower cognitive performance, longer times for 
task solving and more variable performance on the task in Healthy Elderly (Hsieh & Lin, 
2017; Speer & Soldan, 2015). In Healthy Young and Healthy Elderly lower P1 amplitude 
in response to faces and cars in high and low contrast were related to higher intra-
individual reaction time variability of the Stroop task for the incongruent condition in the 
Healthy Elderly. However, after removing 4 outliers scoring 2 SD below the mean the 
correlations between P1 amplitude and CVRT of the Stroop task for the incongruent 
condition did not remain significant (p > 0.15). After removing one outlier scoring 2 SD 
above the mean within the group intra-individual reaction time variability of the Stroop 
task for the congruent condition did not correlate with P1 amplitude in Healthy Young (p 






3.3.9. Time-frequency bands 
To investigate age differences in power change of different frequency bands we 
compared Healthy Young and Healthy Elderly expecting higher change in theta power 
in Healthy Elderly reflecting cognitive changes (Lithfous et al., 2015). Figure 3.11 
shows power changes in alpha, beta, gamma and theta frequency bands after stimulus 
presentation. Theta power is higher in Healthy Elderly compared to Healthy Young 
(Young: 0.39 %, Elderly: 0.83 %, F(1,44) = 7.23, p = 0.01). As shown in Figure 3.12 
(high contrast) and Supplementary Figure S.3.2 (low contrast) Healthy Elderly had 
increased power change in theta for high Contrast condition for faces images and 
scrambled compared to Healthy Young. This is supported by the interaction effect of 
“Contrast x Category x Group” and Bonferroni corrected comparisons, p < 0.0083 
(Table 3.4) (F(1,44) = 7.09, p = 0.004; Contrast 10%: faces t(44) = -1.26, p = 0.21; cars 
t(44) = -1.30, p = 0.19; scrambled t(44) = -1.93, p = 0.06; Contrast 100%: faces t(44) = -





Figure 3.11: Time frequency spectra for high and low contrast condition in Healthy Young and 
Healthy Elderly. Changes in frequency power displayed on the y axis, ranging from 500 ms before 
stimulus onset at 0 seconds displayed on the x axis and 500 ms after stimulus onset separated group for 
stimulus type A) faces, B) cars and C) scrambled, Healthy Young and Healthy Elderly D) faces, E) cars, 
F) scrambled, right high contrast condition and low contrast condition on the left. 
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Table 3.4: Spectral Power Change: Repeated measures mixed ANOVA of power change in alpha, 
beta, gamma and theta frequency bands with the factors contrast, category and group of Healthy 
Young (N = 22) and Healthy Elderly (N = 24) 
 Alpha Beta Gamma Theta 
 F (p) F (p) F (p) F (p) 
Contrast 14.41 (= 0.0004)**  1.44 (= 0.24) 0.001 (= 0.98) 52.09 (< 0.0001)** 
Category 8.33 (= 0.001)** 0.44 (= 0.65) 3.12 (= 0.052) 25.82(< 0.0001)** 
Group 1.08 (= 0.31) 0.42 (= 0.51) 0.99 (= 0.33) 7.23 (= 0.010)* 
Contrast x 
Group 
0.19 (= 0.66) 0.001 (= 0.98) 0.42 (= 0.52) 11.23 (= 0.002)** 
Category x 
Group 




1.00 (= 0.37) 1.56 (= 0.22) 0.75 (= 0.46) 7.09 (= 0.004)** 
Contrast x 
Category 
9.09 (= 0.0003)** 0.72 (= 0.49) 0.15 (= 0.84) 23.69 (< 0.0001)** 
Between-subjects factor: Group: 2 Levels: Young, Elderly                                                                           
Within-subjects factors: Category: 3 levels: face, car, Contrast: 2 levels: contrast 10%, contrast 100%                                                                                                                                                                 





Figure 3.12: Group Differences in change of Theta power of the high contrast condition. Average 
percentage of Theta power change, separated by stimulus type, A) face or B) car, and C) scrambled 
image and by subject group, Healthy Young (N = 22) in green and Healthy Elderly (N = 24) in gray. On 
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the left in all panels, means of the theta power change across subjects in each group are shown. Error 
bars denote S.E.M. across subjects.  In the center power change in different frequency bands of interest 
such as alpha, beta, gamma and theta and on the right spatial distribution of change in theta power of the 
high contrast condition are shown. * denotes a significant difference, p < 0.05 (black star as assessed by 
the ANOVA and post-hoc tests) ** denotes a significant difference, p < 0.005 (black star as assessed by 
the ANOVA and post-hoc tests).  
 
3.3.10. Correlation of change in Theta power and cognitive measurements 
To test wether differences in power change of theta reflect changes in cognition we 
correlated power change in theta and scores on cognitive tests such as the Trail Making 
Test and Stroop Test expecting higher power change being related to worse 
performance (Lithfous et al., 2015). As shown in Figure 3.13 higher change in theta 
power correlates with lower variability of noncongruent Stroop condition in Healthy 
Elderly, which remain stable after removing 5 outliers that deviated ±2 SD from the 




Figure 3.13: Association of change in Theta power and coefficient reaction time variability of 
Stroop incongruent condition. Correlation change in Theta power for A) faces B) cars and C) 
scrambled images (left) Contrast 10% and (right) Contrast 100% displayed on the y-axis and coefficient 
reaction time variability of Stroop task incongruent condition on the x-axis. Green dots show the individual 
values of Healthy Young volunteers (N = 21(without outlier) and grey dots the individual values of Healthy 
Elderly volunteers (N = 19 (without outlier)). 
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3.3.11. Variability Quenching 
To test age differences in neural variability we compared percent change between 
Healthy Young and Healthy Elderly expecting lower variability quenching in Healthy 
Elderly indicating variability quenching as a possible mechanism of cognitive changes 
and increase in behavioral variability. Figure 3.14 illustrates that in both groups, Healthy 
Young and Healthy Elderly volunteers, increased quenching 100 – 400 ms after 
stimulus presentation for the low contrast condition (Table 3.5), especially for faces and 
cars (Young: Contrast 10% vs. Contrast 100%: average: t(21) = -6.70, p < 0.0001; 
faces: t(21) =  -4.79, p < 0.0001; cars: t(21) = -4.16, p = 0.0004; scrambled: t(21) = -
2.56, p = 0.02; Elderly: Contrast 10% vs. Contrast 100%: average: t(23) = -4.57, p = 
0.0001; faces: t(23) = -3.13, p = 0.005; cars: t(23) = -3.02, p = 0.0061; scrambled: t(23) 
= -0.65, p = 0.52) Bonferroni corrected (for eight comparisons, four within each group) 
significance threshold  was p < 0.00625. We exploratory tested whether quenching was 
time dependent and tested separately three time intervals after stimulus presentation. 
All time windows showed comparable stable effects of contrast condition but no group 
differences (Table 3.5). Only the time window 200 – 300 ms after stimulus presentation 
showed an interaction effect of “Group x Contrast” (F(1, 44) = 4.18, p = 0.047). Post- 
hoc comparisons showed that there is no difference between Healthy Elderly and 
Healthy Young for low and high contrast condition (Contrast 10%: t(44) = 0.69, p = 0.49; 
Contrast 100%: t(44) = 16, p = 0.88). The interaction effect is explained by higher 
increase in variability quenching between high and low contrast condition in Healthy 
Young compared to Healthy Elderly (t(44) = 2.04, p = 0.047) albeit not significant after 
Bonferroni correction for multiple comparisons (p < 0.016). 
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Table 3.5: Variability Quenching: Repeated measures mixed ANOVA with the factors contrast, 
category and group of Healthy Young (N = 22) and Healthy Elderly (N = 24)  
 Variability 
Quenching  















300-400 ms after 
stimulus 
presentation 
 F (p) F (p) F (p) F (p) 








Category 1.81 (= 0.17) 3.62 (= 0.03)* 2.56 (= 0.08) 4.62 (= 0.01)* 
Group 0.34 (= 0.56) 2.59 (= 0.11) 0.05 (= 0.82) 0.03 (= 0.87) 
Contrast x 
Group 
3.39 (= 0.07) 1.02 (= 0.32) 4.18 (= 0.047)* 2.92 (= 0.09) 
Category x 
Group 




0.03 (= 0.97) 0.12 (= 0.89) 0.08 (= 0.92) 0.07 (= 0.91) 
Contrast x 
Category 
5.39 (= 0.007)* 3.23 (= 0.046)* 7.01 (= 0.002)** 4.96 (= 0.01)* 
Between-subjects factor: Group: 2 Levels: Young, Elderly                                                                           
Within-subjects factors: Category: 3 levels: face, car, Contrast: 2 levels: contrast 10%, contrast 100%                                                                                                                                                                 




Figure 3.14: Variability Quenching 100-400 ms after stimulus presentation. Difference in percent 
change in high and low contrast condition in Healthy Young (N = 22) (upper) and Healthy Elderly (N = 24) 
(lower). *denotes Bonferroni corrected significance threshold p < 0.00625 **denotes a significant 
difference, p < 0.005 (black star as assessed by the ANOVA). 
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3.3.12. Correlation of Variability Quenching and cognitive measurements 
To investigate whether neural variability is related to cognitive differences we correlated 
percent change of variability quenching with scores on the Trail Making Test expecting 
higher variability quenching being related to less time required to solve the task (Arazi, 
Censor, et al., 2017). As shown in Figure 3.15 in Healthy Elderly subjects increased 
time to solve Trail Making Test part A correlated with increased quenching for the high 
and low contrast condition (Contrast 10%: rs = -0.49, p = 0.02; Contrast 100%; rs = -
0.49, p = 0.01). The correlation remains stable after removing 7 outliers scoring ±2SD 
away from the mean, between Trail Making Test part A and variability quenching of the 
low contrast condition in Healthy Elderly (Contrast 10%: rs = -0.49, p = 0.03; faces: rs = -
0.39, p = 0.10; cars: rs = -0.50, p = 0.03, scrambled: rs = -0.56, p = 0.01; Contrast 100%: 
rs = -0.39, p = 0.09; faces: rs = -0.43, p = 0.07, cars: rs = -0.27, p = 0.27, scrambled: rs = 
-0.52, p = 0.02). Increased variability quenching in response to high contrast scrambled 
images is related to longer times to solve the Trail Making Test part A and part B in 





Figure 3.15: Relation of Variability quenching and Trail Making Test part A. A) Correlation between 
Percent change for Contrast 10% A) faces B) cars and C) scrambled images left Contrast 10% and right 
Contrast 100% displayed on the y-axis and time solving Trail Making Test part A on the x-axis. Green 
dots show the individual values of Healthy Young volunteers (N = 20(without outlier)) and grey dots the 
individual values of Healthy Elderly volunteers (N =  19(without outlier)). 
142 
 
In Healthy Young volunteers increased time to solve the slightly more complex Trail 
Making Test part B was related to reduced quenching in low contrast condition and for 
scrambled images in the high and low contrast condition (Contrast 10%: rs = 0.50, p = 
0.02; Contrast 100%: rs = 0.52, p = 0.01). After excluding seven influential observations, 
±2SD deviant from the average within the group only the correlation for higher 
quenching of the average of the low contrast stimuli and low contrast facial images and 
less time for the TMT part B was significant in Healthy Young volunteers (Contrast 10%: 
rs = 45, p = 0.044: faces: rs = 0.52, p = 0.02; cars: rs = 0.39, p = 0.08; scrambled: rs = 
0.44, p = 0.051; Contrast 100%: rs = 0.32, p = 0.16, faces: rs = 25, p = 0.28; cars = 0.26, 




Figure 3.16. Relation of Variability Quenching and Trail Making Test part B. Correlation between 
Percent change for Contrast 10% A) faces B) cars and C) scrambled images left Contrast 10% and right 
Contrast 100% displayed on the y-axis and time solving Trail Making Test part A on the x-axis. Green 
dots show the individual values of Healthy Young volunteers (N = 20(without outlier)) and grey dots the 
individual values of Healthy Elderly volunteers (N =  19(without outlier)). 
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To test whether variability quenching is related to behavioral variability we correlated 
CVRT and percentage change of variability quenching. Behavioral variability and 
variability quenching were not correlated in both groups. To investigate whether correct 
responses were related to increased variability quenching we correlated proportion 
correct responses with percentage change of variability quenching (Arazi, Censor, et al., 
2017). Only proportion correct categorization for high contrast faces were related to 
variability quenching in Healthy Young (rs = 0.47, p = 0.03). However, removing three 
influential observations scoring 2SD below the mean the correlation did not remain 
stable (rs = 0.45, p = 0.051). 
3.3.13. Heart Rate Variability 
To investigate whether HRV reflects changes in age we tested differences in HRV 
expecting higher HRV in Healthy Young. In accordance with previous research HRV 
parameter such as RMSSD, High frequency power and low frequency power were 
reduced in Healthy Elderly (Shaffer et al., 2014) (Table 3.6, Figure 3.17). 
Table 3.17: Heart Rate Variability: Group differences in Heart Rate Variability between Healthy 
Young (N = 20) and Healthy Elderly (N = 22)  
 Pre task Resting state During the task Post task Resting state 
 t (p) t (p) t (p) 
RMSSD 1.83 (= 0.07) 3.45 (= 0.001)** 2.88 (= 0.006)# 
LF power (ms2) 1.55 (= 0.13) 31.28 (< 0.0001)** 1.57 (= 0.12) 
HF power (ms2) 1.08 (= 0.29) 2.64 ( = 0.01)# 2.31 (= 0.03)# 
LF / HF ratio (ms2) -0.89 (= 0.39) 0.85 (= 0.40) -0.82 (= 0.42) 





Figure 3.17: Heart rate variability differences between Healthy Young and Healthy Elderly. (A) Root 
Mean Square of Successive Differences (left) High Frequency power (middle) and Low frequency power 
(right) for Healthy Young (N = 20) green bars and Healthy Elderly (N = 24) black bars. Error bars show 
the standard error of the mean. ** denotes a significant difference between Healthy Young and Healthy 
Elderly, p < 0.005 (black star as assessed by t-test) in the Resting state (2 min.) before the task (B) 
during the task (C) in the Resting state (2 min.) after the task. 
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3.3.14. Correlation of Heart Rate Variability, cognitive measurements and task 
measurements 
To investigate whether HRV is related to cognitive changes in Healthy Elderly and in 
Healthy Young we correlated different HRV parameters with scores on different 
cognitive tests such as the Trail Making Test expecting higher cognitive performance 
being related to higher HRV (Thayer et al., 2009). Lower RMSSD during the task 
correlated with faster solving of the Trail Making Test part A in the Healthy Elderly (rs = 
0.48, p = 0.02). This correlation did not remain stable after removing 2 outlier scoring 
±2SD away from the average within the group (rs = 0.31, p = 0.81). Increased LF power 
is related to faster solving of the Trail Making Test part A in the Healthy Young (rs = -
0.56, p = 0.01) which did not remain stable after removing 2 influential observation 
scoring 2SD above the mean of within the group (rs = -0.46, p = 0.058). 
To investigate whether HRV reflects behavioral changes we correlated different HRV 
parameters with task measures of behavioral variability expecting higher HRV being 
related to higher intra- individual variability. First, we correlated average coefficient of 
recognition time variability separately for high and low contrast stimuli with HRV 
measures. In both groups, Healthy Young and Healthy Elderly, both conditions did not 
correlate with the HRV measures (p > 0.061). However, after separating the conditions 
for the different type of stimuli, higher behavioral variability in response in low contrast 
cars and scrambled images was related to higher RMSSD in Healthy Young (Contrast 
10%: cars: rs = 0.47, p = 0.036; scrambled: rs = 0.45, p = 0.045). Higher behavioral 
variability in response to scrambled images was correlated with higher LF power in 
Healthy Young (rs = 0.51, p = 0.02). After removing 2 influential observations scoring 
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2SD above the mean within the group higher RMSSD correlated with increased intra-
individual variability in response to low contrast cars in Healthy Young (RMSSD: rs = 
0.48, p = 0.045 (Supplementary Figure S3.3). In Healthy Elderly, after removing four 
influential observation scoring 2 SD above the average within the group, higher 
RMSSD, LF power and HF power correlated with lower intra-individual variability in 
response to high contrast cars (RMSSD: rs = -0.54, p = 0.02 (Supplementary Figure 
S3.3); LF: rs = -0.52, p = 0.03; HF: rs = -0.65, p = 0.004). However, given that behavioral 
variability for only one high contrast condition correlated with HRV this results seems 
unreliable. 
To test whether ERP’s are related to differences in cardiac variability we correlated 
amplitude of P1 and P3 with HRV parameters expecting higher amplitudes to be related 
to higher heart rate variability. First, we correlated average amplitude of the P1 and P3 
component separately for high and low contrast stimuli with HRV measures. In both 
groups, Healthy Young and Healthy Elderly, both conditions did not correlate with the 
HRV measures (p > 0.15). However, after separating the conditions for the different type 
of stimuli, only higher P1 amplitude in response to low contrast faces was related to 
lower HF power in Healthy Young (rs = -0.46, p = 0.043) which did not remain stable 
after removing two outliers scoring 2 SD above the average within the group (rs = -0.46, 
p = 0.06).  
To test whether change in theta power is related to differences in HRV we correlated 
power change with HRV parameters expecting higher power change being related to 
lower HRV. First, we correlated average change in theta power separately for high and 
low contrast stimuli with HRV measures. In both groups, Healthy Young and Healthy 
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Elderly, both conditions did not correlate with the HRV measures (p > 0.22). Higher 
change in theta power in response to high contrast scrambled images correlated with 
higher LF to HF power in Healthy Elderly (rs = 0.43, p = 0.044) which did not remain 
stable after removing three outliers (rs = 43, p = 0.07). 
To investigate whether neural variability and HRV indicate changes in cognitive aging 
resulting from the same underlying mechanism such as prefrontal deficiency (Frewen et 
al., 2013; Thayer et al., 2009), we correlated the different HRV parameters with percent 
change in variability quenching. We expected higher variability quenching being related 
to higher HRV. Higher variability quenching in response to high and low contrast 
condition was related to lower LF to HF ratio (Contrast 10%: average: rs = -0.54, p = 
0.01; cars: rs = -0.54; p = 0.01, scrambled: r = -0.56, p = 0.01; Contrast 100%: average: 
rs = -0.45, p = 0.047; cars: rs = -0.47, p = 0.037, scrambled: rs = -0.53, p = 0.02) which 
did not remain stable after removing 4 outliers scoring 2 SD away from the mean within 
the group (Contrast 10%: average: rs = -0.47, p = 0.14; cars: rs = -0.41, p = 0.12, 
scrambled: rs = -0.47, p = 0.07; Contrast 100%: cars: rs = -0.32, p = 0.23; scrambled: rs 
= -0.46, p = 0.07).  
Higher variability quenching in response to low contrast condition was related to higher 
LF power in Healthy Young (Contrast 10%: average: rs = 0.47, p = 0.037; cars: rs = 0.47, 
p = 0.03; scrambled: rs = 0.52, p = 0.02). However, after removing 2 influential 
observations the correlations did not remain stable (Contrast 10%: average: rs = -0.02, p 
= 0.94; cars: rs = -0.001, p = 0.98: scrambled: r = 0.04, p = 0.89). These results indicate 
that HRV in Healthy Young and Elderly is not related to variability quenching in 




Our results show that healthy individuals independent of their age show higher 
behavioral variability, higher P3, higher change in theta power and lower neural 
variability in response to a high contrast stimulus. Healthy Elderly need more time for 
solving standardized cognitive tests, Trail Making part A and B and Stroop Test 
congruent and noncongruent condition. Considering the task measurements Healthy 
Elderly show higher recognition time variability for cars, reduced P1 and P3 Amplitude, 
higher change of theta power and lower cardiac variability compared to Healthy Young. 
Moreover, we could show that lower cognitive performance in Healthy Elderly is related 
to higher behavioral, driven by low contrast condition and lower neural variability. 
3.4.1. Comparison with previous findings on intra-individual variability in 
recognition times 
Previous research showed that healthy older adults show increased intra-individual 
variability compared to young adults in tasks using simple stimuli such as circles and 
flickers. This effect is more pronounced in older adults, 60 plus, than for middle aged 
adults 40 to 60 and for choice reaction time task compared to simple RT tasks (Dykiert, 
Der, Starr, & Deary, 2012). This is consistent with our results as we do not find 
differences in CVRT of the simple RT task but for the Stroop task and for the cars 
condition of our image recognition task. In Healthy Elderly worse cognitive performance 
was related to increased behavioral variability in low contrast condition. This goes in line 
with the findings that intra-individual variability of reaction times predicts age-related 
cognitive decline (Bielak et al., 2010; Gorus et al., 2008; MacDonald et al., 2006) and 
mortality (Haynes, Bauermeister, & Bunce, 2017). Moreover, our results show that 
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behavioral responses such as intra-individual variability to low contrast stimuli might be 
more effective to predict cognitive changes as measured by standardized tasks as the 
Trail Making Test in Healthy Elderly. 
3.4.2. Event Related Potentials 
We showed that Healthy Elderly are characterized by lower P1 in response to low 
contrast condition and lower P3 in response to high contrast condition. Lower P1 
amplitude is consistent with previous findings in Healthy Elderly (Stothart et al., 2014). 
However, previous research shows inconsistent findings such as increased P1 
amplitude in Healthy Elderly (Falkenstein, Yordanova, & Kolev, 2006) indicating that P1 
might be a less stable indicator of perceptual and cognitive changes in aging. Lower P3 
amplitude characterizes elderly with cognitive decline such as MCI and dementia 
(Morrison, Rabipour, Taler, Sheppard, & Knoefel, 2019) and in healthy middle aged 
compared to Healthy Young adults (Bourisly, 2016) reflecting changes in cognitive 
function. Consistent with previous research we could show reduced cognitive 
functioning as indicated by worser performance on the Trail Making Test part A and B 
and lower P3 amplitude in Healthy Elderly, especially in the high contrast condition. This 
shows that high contrast stimuli are probably more sensitive in indicating cognitive 
change by decrease in P3. 
3.4.3. Time-frequency bands 
Our finding of increase in theta power supports findings in PD patients with MCI (He, 
Zhang, Chen, Xie, Gan, Wang, et al., 2017). Increase in theta power predicts cognitive 
decline in PD (Cozac et al., 2016). Increase in theta power is correlated with cognitive 
impairment and predicts cognitive declines in PD patients (Geraedts et al., 2018) 
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indicating its potential as a marker of cognitive decline. Our results did not show a 
relation between attention measures such as Trail Making Test and theta power. 
However, we could show a relation between higher theta power and lower variability 
performance on the Stroop Test in Healthy Elderly. This might be probably explained by 
differences in the montage or cognitive measures that were used. 
3.4.4. Neural variability  
Previous research reported that increased variability quenching is related to better 
perceptual performance in Healthy Young individuals (Arazi, Censor, et al., 2017). We 
did not find group differences in variability quenching between Healthy Young and 
Healthy Elderly. However, in response to the different contrast conditions of our task we 
found lower variability quenching for the low contrast condition compared to the high 
contrast condition in Healthy Young and Healthy Elderly. Variability quenching might 
increase the signal to noise ratio and thereby improve signal processing while 
processing the stimuli of the more difficult low contrast condition (Churchland et al., 
2010). Moreover, lower neural variability correlated with lower cognitive performance in 
Healthy Elderly consistent with previous findings in elderly and slower performing adults 
(Garrett et al., 2013) as well as during maturation (McIntosh, Kovacevic, & Itier, 2008). 
This might indicate that in phases of change in cognitive capacity such as maturation 
(McIntosh et al., 2008) and aging increase in neural variability reflect better cognitive 
state. However, higher neural variability correlated with lower attention performance in 
Healthy Young only which can be interpreted as consistent with previous research 
(Arazi, Censor, et al., 2017). This might indicate that lower neural variability reflects 
better cognitive performance in Healthy Young. Moreover, neural variability is stable 
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over time and across tasks in Healthy Young human volunteers (Arazi, Gonen-Yaacovi, 
et al., 2017) showing its reliability as a possible marker of cognitive changes. 
Nevertheless, older adults and slower performing adults had been reported to show 
fewer changes in brain variability (Garrett et al., 2013).  
3.4.5. Heart rate variability 
Consistent with previous research Healthy Elderly showed lower HRV compared to 
Healthy Young (Abhishekh et al., 2013). Previous research on the relation between 
cognitive functions and HRV are inconsistent and might be related to characteristics of 
different groups(Britton et al., 2008; Frewen et al., 2013; D. H. Kim et al., 2006; Thayer 
et al., 2009). HRV probably reflects sustained attention as measured by continous 
performance tests (Thayer et al., 2009) and memory as measured by the subtest of the 
MOCA (Frewen et al., 2013) in contrast to executive measures such the  the Trail 
Making Test and the Stroop Test. 
3.4.6. Limitations and Future directions 
One limitation is the small subgroup sample size. Reliability of the analysis would 
benefit from increase in sample size of the Healthy Elderly and Healthy Young. Another 
limitation is that our groups shows contradictory result with faster recognition times in 
the Healthy Elderly which can not be explained by incidental buttom pressing. 
Recognition times were slower than 200 ms (Nagel et al., 2009). A possible explanation 
might be higher impulsivity in Healthy Elderly. Future studies might benefit by 
assessment of inhibitory control. Medication might be another factor which might have 
influenced our cardiac measurements. As certain factors such as cardioactive 
medication, menstrual cycle, estrogen therapy (Aronson & Burger, 2001; von Holzen, 
153 
 
Capaldo, Wilhelm, & Stute, 2016), smoking, gender and caffeine intake  (Dömötör, 
Szemerszky, & Köteles, 2015; Tegegne, Man, van Roon, Riese, & Snieder, 2018) might 
influence cardiac measurements future studies could asses these variables and include 
them in control analyses or exclude these influences in sample selection. Furthermore, 
other interesting marker of cognitive changes in aging might be heart evoked potential 
showing a heart related EEG response which had been shown to be related to arousal 
and attention (Luft & Bhattacharya, 2015; Montoya, Schandry, & Müller, 1993). 
Moreover, as cognitive changes might be more reflected by frontal electrodes (Saliasi, 
Geerligs, Lorist, & Maurits, 2013) these should be investigated in future research 
probably providing more sensitive measurements of age related cognitive changes. 
3.4.7. Conclusion 
Healthy aging is characterized by cognitive, neural and cardiac changes. Our results 
indicate that worsening of cognitive performance might be characterized by increase in 
behavioral variability and lower neural variability in healthy elderly. Both, behavioral and 
neural variability are non-invasive, probably early markers of cognitive decline. 
Variability quenching is a quite novel measurement in clinical groups which needs 
further investigation in different age groups to prove its potential in progression of 
cognitive decline and probably neurodegenerative disorders such as Parkinson’s 
disease, Lewy Body dementia and Alzheimer’s disease and its suitability as a marker of 
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Supplementary Figure S3.1: Association of P1 Amplitude and coefficient of reaction time 
variability of incongruent condition of the Stroop task. Correlation between P1 amplitude for A) faces 
B) cars and C) scrambled images left Contrast 10% and right Contrast 100% displayed on the y-axis and 
coefficient of reaction time variability of the Stroop task on the x-axis. Green dots show the individual 
values of Healthy Young volunteers (N = 22) and grey dots the individual values of Healthy Elderly 






Supplementary Figure S3.2: Theta power of the low contrast condition. Average percentage of 
Theta power change, separated by stimulus type, A) face or B) car, and C) scrambled image and by 
subject group, Healthy Young (N = 22) in green and Healthy Elderly (N = 24) in gray. On the left in all 
panels, means of the theta power change across subjects in each group are shown. Error bars denote 
171 
 
S.E.M. across subjects.  In the center power change in different frequency bands of interest such as 
alpha, beta, gamma and theta are shown. * denotes a significant difference, p < 0.05 (black star as 
assessed by the ANOVA and post-hoc tests) ** denotes a significant difference, p < 0.005 (black star as 
assessed by the ANOVA and post-hoc tests). 
 
 
Supplementary Figure S3.3: Relation of Heart Rate Variability (RMSSD) during the task and 
behavioral variability. Correlation between intra-individual variability of A) faces B) cars and C) 
scrambled images left Contrast 10% and right Contrast 100% displayed on the y-axis and RMSSD on the 
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x-axis. Green dots show the individual values of Healthy Young volunteers (N = 18(without outlier)) and 




4. General Discussion 
This thesis examined objective and quatifiable measures of visual misperceptions and 
behavioral variability in Parkinson’s disease. 1)Differences between hallucinating and 
non-hallucinating PD patients in perceptual error score and behavioral variability and the 
relation to reduced functional connectivity between attentional networks and perceptual 
errors and reduced functional connectivity between somatomotor and fronto-parietal 
network and behavioral variability are discussed from the perspective of behavioral and 
neural models. 2) Differences in P1, P3 amplitude, theta power, HRV between Healthy 
Young and Healthy Elderly and the relation of behavioral and neural variability to 
cognitive measures in Healthy Elderly are discussed from the perspective of different 
behavioral, cognitive, neural and cardiac models. The major topic of this thesis focused 
on the discussion of the potential of different objective measures such as 
psychophysical performance, variability quenching and fuctional connectivity as possible 
marker of different non-motor symptoms phenotypes in PD as well as potential 
diagnostic implications. 
4.1. Non-motor symptoms in Parkinson’s disease 
Non-motor symptoms in PD can be described in terms of impairments which can be 
measured by psychophysical performance. Cognitive symptoms can be categorized in 
different domains such as memory deficits, attentional deficits, executive dysfunction 
and visuoperceptual deficits. To measure memory deficits, recognition and semantic 
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memory tasks can be used. Attention deficits can be tested with tasks measuring 
executive control, orienting, arousal and cognitive fluctuations. Tasks measuring 
executive dysfunctions include learning from feedback and cognitive flexibility such as 
rule-shifting, working memory and response inhibition (Gratwicke, Jahanshahi, & 
Foltynie, 2015). Dysfunctions of the different cognitive domains are present in 
neuropathologies such as attentional fluctuations in  ADHD, response disinhibition in 
ICB, attentional deficits and executive dysfunction in MCI, memory and VH in LB 
dementia and VH in schizophrenia but some can also characterize physiological 
changes during the life-span such as age related decline in response inhibition, selective 
and divided attention (Geerligs, Saliasi, Maurits, Renken, & Lorist, 2014; Harada, 
Natelson Love, & Triebel, 2013; Haring et al., 2013). Some processes of the different 
cognitive domains such as increased behavioral variability may be general or shared in 
healthy aging, ADHD, MCI, PD, schizophrenia, LB dementia and PD (Dykiert et al., 
2012; MacDonald et al., 2006; Rentrop et al., 2010; van Belle et al., 2015) while others 
might be more specific such as VH occuring in PD, schizophrenia and LB dementia 
(Shine, O’Callaghan, Halliday, & Lewis, 2014). Objective behavioral measures, which 
are sensitive to different non-motor profiles such as cognitive decline and VH might be 
used for differential diagnostics. 
4.2. Behavioral, neural and cardiac variability in healthy aging  
Intra-individual variability of reaction times is a sensitive predictor for age related 
cognitive decline (Bielak et al., 2010; Gorus et al., 2008; MacDonald et al., 2006). 
Behavioral variability increases in healthy aging (Dykiert et al., 2012) and is predictive 
for transition from healthy aging to mild cognitive impairments (Cherbuin, Sachdev, & 
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Anstey, 2010). The correlation of higher behavioral variability with worse performance on 
the Trail Making Test in healthy elderly is consistent with previous research (Bielak et 
al., 2010; Gorus et al., 2008; MacDonald et al., 2006). We also tested another candidate 
of lower cognitive functioning, HRV in healthy elderly (Frewen et al., 2013; Thayer et al., 
2009). In our group of healthy elderly we did not find a relation between lower HRV and 
cognitive decline. This is probably explained by measurements of different cognitive 
functions. Previous research showed a relation between HRV and sustained attention by 
continous performance tests (Thayer et al., 2009) and between memory recall, language 
subtest of the MOCA (Frewen et al., 2013) which are probably more sensitive in 
detecting HRV and age-related cognitive changes than the Trail Making Test and the 
Stroop Test. Another novel candidate of cognitive decline in healthy aging is neural 
variability. To our knowledge age related differences in variability quenching and their 
relation to cognitive functioning, behavioral variability and cardiac variability were not 
investigated before. Our data shows that worse cognitive performance is related to lower 
neural variability in healthy eldery and higher neural variability in healthy young which 
might be related to differences or changes in cognitive capacity. In contrast to our 
expectations based on previous research showing that neural variability is related to 
perceptual performance (Arazi, Censor, et al., 2017; Schurger, Sarigiannidis, Naccache, 
Sitt, & Dehaene, 2015) we did not find a consistent correlation between neural variability 
and behavioral variability. Possible explanations might be that the task was not complex 
enough for the subtle physiological age related changes. Larger behavioral variability 
mgiht be provoked by more involvement of executive functions and need more complex 
tasks (Dixon et al., 2007; West, Murphy, Armilio, Craik, & Stuss, 2002). However, it is 
also possible that the task was not simple enough to show age related differences in 
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behavioral variability given that differences in behavioral variability are lower for 
cognitively more demanding task (Hultsch, MacDonald, & Dixon, 2002). In case that task 
complexity is driving the effect it would be reasonable to see differences between the 
high contrast condition, being easier to recognize, and low contrast condition which is 
more difficult to recognize. Exploratory analyses, using a separate ANOVA for the low 
and high contrast condition showed that healthy elderly quenched less for the window 
100 to 200 ms after stimulus presentation in the low contrast condition indicating that 
neural variability differentiates between higher and lower performing group in 
perceptually more demanding tasks where healthy young probably improve signal 
processing with increasing the signal to noise ratio by increased variability quenching 
(Churchland, 2010). However, another explanation might also be that the tasks do not 
differ in respect to perceptual demands but in cognitive demands such as shifting or 
dividing attention. Probably a task using a paradigm with additional difficulty such as 
distractors might result in higher behavioral variability which is related to neural 
variability in healthy elderly. Nevertheless, behavioral and neural variability seem to 
reflect general executive functioning in healthy adults and are possible marker of decline 
in executive functions, probably more effective in perceptually demanding conditions. 
4.3. Behavioral variability in Parkinson’s disease 
Behavioral variability is assumed to be sensitive to already detect subtle decline in 
congnition (MacDonald et al., 2006). Increased behavioral variability had been shown to 
be associated with age related cognitive decline (Lövdén, Li, Shing, & Lindenberger, 
2007; MacDonald, Hultsch, & Dixon, 2003) higher risk for development of mild cognitive 
impairment (Bielak et al., 2010; Cherbuin et al., 2010; Kälin et al., 2014) and predicted 
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transition from mild cognitive impairment to dementia (Gorus et al., 2008; Tales et al., 
2012). In prodromal Huntington Disease (Musso et al., 2015) and in untreated PD 
patients behavioral variability was increased (Burton et al., 2006; Camicioli et al., 2008). 
This clearly indicates potential of behavioral variability as an early marker of cognitive 
impairments in neurodegenerative disorders (Costa et al., 2019). Interestingly, 
behavioral variability increased over time in PD patients with mild cognitive impairment 
and dementia compared to PD patients without cognitive decline (de Frias et al., 2012). 
Increased behavioral variability in our sample of hallucinating PD patients indicates 
higher chances for development of cognitive decline in PD-VH (Diederich et al., 2009). 
Given that increased behavioral variability was also shown in another clinical groups 
such ADHD, OCD and ICD who do not experience VH but attentional and inhibitory 
deficits (Abramovitch et al., 2019; Kertzman et al., 2018; Kofler et al., 2013) showing that 
increased behavioral variability is driven by the same deficits in attentional and executive 
function. Thus, objectively task derived intra-individual variability, especially from more 
complex tasks, is a promising marker of attentional and executive dysfunction in different 
neurological disorders.  
4.4. Visual Misperceptions and Hallucinations in Parkinson’s disease 
VH are related to non-motor symptoms of different domains such as depression 
(Holroyd, Currie, & Wooten, 2001), sleep (Sanchez-Ramos et al., 1996) and cognitive 
disturbances (Sanchez-Ramos et al., 1996). Interestingly, especially decline in executive 
function but not episodic memory is related to experience of VH in PD (Creese et al., 
2018). This indicates that executive dysfunction is common to dementia and VH in PD 
but memory deficits are specific for dementia. Execuitve dysfunction consists of different 
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functions such as rule-shifting, response inhibition and working memory (Gratwicke et 
al., 2015). The possible contribution of these different executive functions in explaining 
VH is indicated by increased perceptual errors and behavioral fluctuation of PD-VH as 
shown by our group and increase in percpetual errors and mental imagery in PD-VH 
(Shine, Keogh, et al., 2015). Attentional and inhibitory control of perceptual errors might 
be indicated by network related measurements which were associated with different 
congitive functions (Prell, 2018; Shine, Keogh, et al., 2015). As increased perceptual 
error score in PD-VH was shown to be consistent. It seems to be an objective measure 
to detect those with an increased risk to experience VH, probably even et al early PD 
stage (Kulisevsky & Pagonabarraga, 2009). Nevertheless, additional new neural 
measurements such as functional connectivity of Resting state networks might provide 
additional insights into neural and functional dysfunctions related to different symptom 
profiles and have the advantage of not being influenced by expectations or ideas about 
the desirable performance. 
4.5. Resting state networks in Parkinson’s disease 
Most literature on Resting state fMRI in PD investigated connectivity of motor regions, 
icnluding the somatomotor network (Hohenfeld, Werner, & Reetz, 2018). However, by 
now findings are inconsistent on hypo- and hyperconnectivity of the motor regions 
(Hohenfeld et al., 2018). Moreover, also the default mode network was of main interest 
showing no or only a few differences in DMN connectivity pattern (Hohenfeld et al., 





4.5.1. Visual misperceptions in Parkinson’s disease 
In PD reporting VH increased connectivity within the DMN had been shown (Franciotti et 
al., 2015; Shine, Keogh, et al., 2015; Yao et al., 2015, 2014). In addition, (Shine, Keogh, 
et al., 2015) hyperconnectivity of the DMN was not only related to perceptual errors but 
also to mental imagery. As we did not measure strength of mental imagery in our sample 
it might be possible that our sample differs with respect to mental imagery to other PD-
VH and thereby do not show hyperconnectivity of the DMN. Moreover, as alterations in 
DMN are inconsistent other sample characteristics such as differences in respect to 
motor- and non-motor symtpoms might also be considered in explaining the missing 
DMN hyperactivitiy of our sample. Nevertheless, consistent with previous research we 
found that increase in visual misperceptions is related to hypoconnectivity between 
dorsal attention network and the salience network (Shine, Keogh, et al., 2015). This 
provides support for involvement of attentional and executive dysfunction in VH in PD 
(Shine, Keogh, et al., 2015). Previous imaging studies had shown that connectivity 
between the DAN and the insula and anterior cingulate, which are part of the salience 
network, is reduced in PD patients with MCI (Baggio et al., 2015). Moreover, impulse 
control symptoms were shown to be related to hyperconnectivity within the salience 
netowork (Tessitore et al., 2017). Increased connectivity of the salience network was 
even present in unmedicated PD patients who developed impulse control behaviors 
during disease progression (Tessitore et al., 2016). This indicates that networks involved 
in executive control might be involved in hallucinatory experience. Given that the 
hypoconnectivity between DAN and salience network might be not unique to VH in PD 
combing Resting state function connectivity with other objective measures such as 
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perceptual errors might be more reliable in characterizing PD subgroup at risk for visual 
misperceptions and or VH.  
4.5.2. Behavioral variability  
Previous research on behavioral variability in healthy adults showed that increased 
behavioral variability was related to increased activation of middle frontal areas, right 
inferior parietal and thalamic regions (Bellgrove, Hester, & Garavan, 2004). In healthy 
older adults lower performance variability was related to in creased activity of the inferior 
parietal cortex (Cabeza & Nyberg, 2000; Shannon & Buckner, 2004). Given that fronto-
parietal regions are important for inhibitory control higher task-related recrutment of 
these regions reflects increased need for inhibitory control in healthy indivduals with 
higher behavioral variability (MacDonald et al., 2009). Moreover, lower behavioral 
variability was related to stronger negative correlation between activity of the DMN and 
DAN (Kelly, Uddin, Biswal, Castellanos, & Milham, 2008) indicating that behavioral 
variabiltiy reflects functional coordination between different networks such as reduced 
DMN  and increased DAN (MacDonald et al., 2009). Moreover, in a neuropsychiatric 
disorder of attention and inhibitory control, e.g. ADHD, lower behavioral variability was 
related to increased activity of supplementary pre-motor area, cerebellum and inferior 
parietal lobule and increased behavioral variability was related to higher activity of the 
prefrontal cortex (Simmonds et al., 2007) indicating that coordination of prefrontal, 
parietal and premotor areas and reduced connectivity might contribute to behavioral 
variability. The deficits in attention and inhibitory control seem to be reflected in our 
findings of increased behavioral variability in PD patients being related to 
hypoconnectiviy of SMN and right fronto-parietal network. Changes in sensorimotor-, 
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frontal- and parietal regions were also related with other non-motor symptoms in PD. PD 
patients with fatigue showed involvement of sensorimotor- and frontal network (Li et al., 
2017; Tessitore et al., 2016; Zhang et al., 2017) indicating that behavioral variability 
might reflect periods of fatique or maybe fluctuations in fatique. Moreover, decreased 
connectivity in prefrontal cortex and parieto-occipital junction in PD patients with MCI 
and inferior frontal cortex in demented PD patients indicates that fronto-parietal 
involvement reflects executive dysfunction in behavioral variability. Furthermore, PD 
patients with impulse control disorders are also characterized by involvement of 
somatosensory and prefrontal cortices in response to inhibitory demanding stimuli 
(Politis et al., 2013) and structural changes in meso-limibic, motor and frontal circuits 
indicating a disconnection between associative, sensorimotor and cognitive networks 
(Imperiale et al., 2018). Hypoconnectivity between somatomotor- and fronto-parietal 
network reflects executive dysfunction,  and probably more specific changes in fatique 
and inhibitory control which are reflected by behavioral varibility. Thus, hypoconnectivity 
between somatomotor- and fronto-parietal networks in combination with task derived 
behavioral variability might be a promising marker of changes in executive function in 
PD. 
4.6. Top-down processing in visual misperceptions and behavioral variability in 
Parkinson’s Disease 
Attentional and executive dysfunction seem to contribute to development of visual 
misperceptions (Shine, Keogh, et al., 2015) and behavioral variability in PD. Reduced 
functional connectivity between attentional networks in visual misperceptions and 
reduced connectivity to fronto-parietal network in behavioral variabiltiy indicate 
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impairments in top-down executive control. Given that minor halluciations precede VH 
(Fénelon et al., 2000) and that hallucinating PD patients show increase in perceptual 
errors (Miloserdov, et al., submitted; Shine, Keogh, et al., 2015) perceptual errors might 
not be corrected by redirecting attention due to disconnection with the DAN (Shine, 
Keogh, et al., 2015) and relying on the saliency of stimuli (Seeley et al., 2007) leading to 
manifestation of the perceptual error as misperception of reality. Impairments of top-
down modulation from the fronto-parietal network resulting in increased behavioral 
variabiltiy might be explained by disinhition and fluctuations in arousal. Thus, both, visual 
misperceptions and behavioral variability might result from deficits in dop-down 
processes. Tools measuring different levels of these top-down dysfunction in visual 
misperceptions and behavioral variability might contribute to differential diagnosis in PD. 
4.7. Diagnostic Tools for differential diagnosis of different PD phenotypes 
Cognitive changes seems to be a common component to visual mispercpetions and 
behaviroal variability and can be assessed by standardized rating scales such as 
MMSE, FAB, Mattis Dementia Rating Scale, MDR-UPDRS (Kulisevsky & 
Pagonabarraga, 2009). Regarding hallucinations specific scales assesing different 
domains such as visual, auditory, tactile and olfactory are still needed. Especially for 
minor hallucinations such as misperceptions and passage hallucinations standardized 
rating scales are missing. Our task derived measures provide a possible tool for 
objective assessment of visual misperceptions as measured by perceptual errors and 
cognitive changes as measured by behavioral variability. Possible new candidates for 
objective and unbiased assessment are EEG task correlates such as P1, P3 amplitude, 
theta power change and neural variability which need further investigation in PD and 
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other groups with executive dysfunction such as ADHD, PD-MCI, ICD and OCD. Resting 
state measurements might be quite promising objective and convenient diagnostic tools 
without possible confounds of misunderstanding task instructions or the tendency to 
perform in a desirable way. Possible promising markers of cognitive decline and VH 
might be derived from Resting state functional connectivity with hypoconnectivity 
between somatomotor- and fronto-parietal network and disconnection between 
attentional networks. Successful recognition of patient groups at risk for VH and 
cognitive decline might influence treatment choices and could be beneficial in 
management of non-motor symptoms during disease progression. 
4.8. Implications for Treatment 
Pharmacological treatment for the prominent motor symptoms consist among other 
options of dopaminergic mediaction with levodopa and dopamine agonists. Levodopa 
therapy can improve cognitive flexibility but worsen executive functions (Dirnberger & 
Jahanshahi, 2013). PD patients treated with dopamine agonist reported higher 
frequency of hallucinations (Baker et al., 2009; Stowe et al., 2008). Patients suffering 
from cognitive decline and VH show improvement under cholinesterase inhibitors (Emre 
et al., 2004; Litvinenko, Odinak, Mogilnaya, & Emelin, 2008). Little evidence is available 
on antidepressants with citalopram and risperidone showing improvements (Pollock et 
al., 2007). VH in PD improve under certain antipsychotics such as Clozapine (Parkinson 
Study Group, 1999; Pollak et al., 2004) and risperidone, which has adverse impact on 
motor symptoms (Ellis, Cudkowicz, Sexton, & Growdon, 2000; Ford, Lynch, & Greene, 
1994; Iketani, Kawasaki, & Yamada, 2017). Brain stimulation, such as electroconvulsive 
therapy is seldom applied and shows inconsistent results on improvement of psychotic 
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symptoms (Burton et al., 2006; Nishioka et al., 2014). Non-invasive brain stimulation 
shows conflicting results on improvement of cognitive state in PD (Hindle, Petrelli, Clare, 
& Kalbe, 2013). These treatment studies indicate that for PD patients at risk for cognitive 
decline levodopa dose and for PD patients at risk for visual misperceptions and VH 
dopamine agonist dose should be chosen carefully. Both non-symptoms profiles seem 
to benefit from cholinesterase inhibitors such as rivastigmine. Pharmacological treatment 
is of course by now the main strategy. However, non-pharmacological treatment might 
be an effective complementary therapy and might gain on importance in the case that 
PD pateint groups at risk for cognitive decline and VH would be recognized at an early 
stage when symptoms are quite subtle. Cognitive training improves different cognitive 
domains such as working memory, executive functioning and processing speed (Leung 
et al., 2015). Non-pharmacological treatment can also have positive effects on other 
non-motor symptoms such as VH by treatement aimed to reduced primary visual deficits 
(Singh & Sørensen, 2011). Coping strategies to reduce hallucinatory experience include 
focusing on the VH or focusing on something different (Diederich, Pieri, & Goetz, 2003). 
Moreover, an unexpected finding of a medication study was that social interactions in 
the setting of a brief psychological treatment improved psychotic symptoms (Swann et 
al., 2011). Non-pharmacological treatment for cognitive decline and VH might be 
beneficial at an early disease stage. Unfortunately the potential of cognitive, behavioral 
and psychological interventions is understudied. 
4.9. Limitations  
One limitation considers the generazability of our findings. Especially the functional 
connectivity findings of our clinical study described in Chapter 2 is limited by the small 
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sample size of sixteen PD patients. For this reason we could not correct for multiple 
tests and because of the low statistical power the generalizability of the negative 
corelational results is also limited. Another limitation of generalizability is healthy aging 
as a model for investigation of possible new marker of cognitive decline such as  
behavioral, neural and cardiac variability. Expecially with respect to neural variability 
where insights from previous research in healthy young adults is very limited 
approaching its potential as an objective measure of cognitive decline in healthy elderly 
was very useful to explore task related parameters. However, we cannot ignore the 
possiblity that development of cognitive decline in PD might differ from healthy aging.  
4.9.1. Behavioral Variability 
Another limitations is the debateable question of the source of behavioral variability. 
Evidence from ADHD research shows that behavioral variability might be related to 
deficits in attention (Wåhlstedt, Thorell, & Bohlin, 2009) and or inhibitory control (Buzy, 
Medoff, & Schweitzer, 2009; Epstein et al., 2003) or their interaction (Clarke et al., 
2007). In ADHD behavioral variability might reflect changes in impulsivity rather than 
attentional fluctuations (Kofler et al., 2013). However, more research is needed to clarify 
the cognitive domain reflected by behavioral variability. Furthermore, we did not 
investigate whether certain stimuli might be more sensitive in provoking behavioral 
variability. Having a closer look at difference in behavioral variability for different stimuli, 
PD patients with VH show higher behavioral variability for faces and healthy elderly 
show a correlation between higher variability for faces and worse performance on the 
Trail Making Test, indicating that facial stimuli might provoke more variable responses in 
individuals with more cognitive decline. Given that PD patients show more deficits in 
recognition of negative emotions (Baggio et al., 2015; Sprengelmeyer et al., 2003) 
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investigating influence of facial emotional stimuli on behavioral variability might be 
promising for detecting different stages of cognitive decline in PD patients.  
4.9.2. Visual hallucinations 
Another limitation is the phenomenology of hallucinatory experience in PD patients. VH 
do not always occur solitary but for a subgroup of patients can be a multimodal 
experience combined with auditory and tactile unreal experiences (Kulick, Montgomery, 
& Nirenberg, 2018). A multimodal task would provide more sensibility and generazibility 
to the subgroup of PD patients at risk for multimodal hallucinations. Moreover, given that 
feeling of presence and passage hallucinations (brief vision of someone or something 
passing sideways) are more frequent than visual misperceptions (Pagonabarraga et al., 
2016) a task which measures perceptual errors of the passage phenomenon probably 
using peripheral movement might be more sensitive and provide an early, maybe even 
premotor, objective behavioral marker of VH in PD.  
4.9.3. Resting state 
The final limitation considers the Resting state measuresment. Resting state with eye 
closed might be problematic as volunteers could move the head slightly (Power, Barnes, 
Snyder, Schlaggar, & Petersen, 2012), fall asleep (Tagliazucchi & Laufs, 2014) and find 
it difficult to be left without a task just staying still (Vanderwal et al., 2015). PD patients 
might move the head more, fall asleep more often and be more distressed without an 
explicit task compared to Healthy Elderly. This might result in differences which 
influence the measure of Resting state functional connectivity. An alternative approach 
which adresses the above described sources of unwanted variation might be a paradigm 




We found promising behavioral and neural candidates for objective and quantifiable 
measurements ofg cognitive decline in Healthy Elderly and VH and cognitive changes in 
PD patients. VH could be objectively indicated by perceptual error scores derived from 
psychophysical perfromance and functional resting state connectivity between the dorsal 
attention network and the salience network (Shine, Keogh, et al., 2015). Generalizing 
from our findings in age related cognitive changes in Healthy Elderly and task 
performance in PD patients, these cognitive changes might be objectively indicated by 
behavioral variability and neural variability in response to psychophysical stimuli and 
functional resting state connectivity between the somatomotor- and the fronto-parietal 
network. Using psychophysical tasks, in combination with EEG and resting state fMRI 
different PD phenotypes might be detected at an earlier stage of the disease and 
probably benefit during the clincial course of the disease by phenotype specified 
treatment. Development of diagnostic tools to facilitate objective identification of different 
sympotmatic PD phenotypes at an early or even subclinical stage would provide the 
possibility to identify patients at risk for VH and cognitive decline. These patients could 
be monitored more cafully to apply more appropriate treatment and support for patients 
and their relatives to sustain quality of life as long as possible and to reduce the burden 
of different non-motor PD symptoms. Future research needs to face the challenge of 
proving measurement reliability in neuropsychological assessment of non-motor 
symptoms and sensitivity of perceptual error score, intra-individual behavioral variability, 
cardiac variability, neural variability and resting state functional connectivity in PD to 
improve differential diagnosis in non-motor symptoms such as visual misperceptions and 
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